Predetermined site luminescence measuring method, predetermined site luminescence measuring apparatus, expression amount measuring method, and measuring apparatus

ABSTRACT

An object of the present invention is to provide a predetermined site luminescence measuring method and a predetermined site luminescence measuring apparatus, which allow for determining whether, when the luminescence from the predetermined site in live samples is measured, a photoprotein is localized at the predetermined site in the same ones as the samples. An predetermined site luminescence measuring apparatus  100  in the present invention is comprised of: a the sample  102  into which a fused fusion gene is introduced, the fusion gene being obtained by fusing a fluorescence-related gene that expresses a fluorescence protein in addition to a targeting base sequence and a luminescence-related gene; a container  103  for storing the sample  102 , a stage  104  on which the container  103  is arranged; a luminescent image capturing unit  106  which captures a luminescent image of the sample  102  (the objective lens  106   a  to the CCD camera  106   c , and the imaging lens  106   f ); a fluorescent image capturing unit  108  which captures a fluorescent image of the sample  102  (the objective lens  108   a  to shutter  108   f ); and an the information communication terminal  110.

RELATED APPLICATION

This application is a continuation of U.S. Ser. No. 11/887,468, filed onSep. 28, 2007, which is a 371 application of PCT/JP2006/306755, filedMar. 30, 2006, which claims priority of Japanese Patent Application No.2005-098608, filed on Mar. 30, 2005, Japanese Patent Application No.2005-104341, filed on Mar. 31, 2005, Japanese Patent Application No.2005-133231, filed on Apr. 28, 2005, and Japanese Patent Application No.2005-337608, filed on Nov. 22, 2005, the entire contents of each ofwhich are incorporated herein by reference.

TECHNICAL FIELD

The present invention relates to a predetermined site luminescencemeasuring method and a predetermined site luminescence measuringapparatus, that measure the luminescence from a predetermined site in alive sample.

The present invention also relates to an expression amount measuringmethod that includes identifying the stage of the cell cycle in livingcells into which a gene to be analyzed are introduced using fluorescencemeasurement in combination with luminescence measurement, and measuringthe amount of expression of the gene to be analyzed.

The present invention further relates to a measuring apparatus thatcaptures an image of a specimen for observation, and more particularlyto a measuring apparatus that is preferably used to observe a specimenlabeled with a luminescent label emitting weak luminescence or afluorescent label emitting fluorescence by excitation.

BACKGROUND ART

(I) ATP is a source of intracellular energy as well as a substancedeeply involved in the life process. On the other hand, fireflyluciferase catalyzes the reaction of forming oxyluciferin, CO₂, AMP, andpyrophosphoric acid through D-luciferin as a luminescent substrate inthe presence of ATP, O₂, and Mg²⁺, thereby producing luminescence.Further, the luminescent reaction of luciferase depends on the amount ofATP.

Therefore, an assay to quantify ATP using the luminescent reaction ofluciferase has been used since a long time ago. In fields, such asbiotechnology, clinical laboratory test, and food hygiene, methods formeasuring the amount of intracellular ATP using luciferase have beendeveloped.

For example, the amount of intracellular ATP is usually measured by thefollowing steps (1-1) to (1-3):

(1-1) dissolving cells or bacteria to extract ATP;

(1-2) adding the extracts to a reaction solution containing luciferinand luciferase; and

(1-3) quantifying the amount of intracellular ATP by measuring theluminescence from the reaction solution to which the extracts are added.

The amount of ATP in the cells which are not homogenized is usuallymeasured by the following steps (2-1) to (2-3):

(2-1) introducing a luciferase gene into cells to obtain expressionthereof;

(2-2) adding luciferin to a culture solution containing cells; and

(2-3) quantifying intracellular ATP by measuring the luminescence fromthe culture solution to which luciferin is added.

The serial measurement of the amount of ATP at a predetermined site(specifically, mitochondria) in living cells is performed by thefollowing steps (3-1) and (3-2) (Non-patent document 1):

(3-1) fusing a mitochondrial targeting signal gene to a luciferase geneand introducing the fused gene into cells; and

(3-2) sequentially measuring changes of the amount of ATP inmitochondria in the cells by measuring the luminescence from the cellson the presupposition that luciferase is localized in mitochondria inthe cells.

Since the intensity of luminescence emitted from cells is very weak,photon counting is performed by using a CCD camera equipped with animage intensifier to recognize one cell. Cells other than the cellswhose amount of luminescence is measured are used to determine whetherluciferase is localized in mitochondria in cells or not. Specifically,the different cells are immobilized and reacted with anti-luciferaseantibodies, and then the cells are observed by a fluorescent antibodymethod in order to confirm their localization. As a result, it issuggested that the amount of luminescence from the measured cellscorresponds to the amount of luminescence from mitochondria.

(II) The cell proliferation is one of the essential and importantcharacteristics for organisms in the vital life processes. The cellcycle includes multiple consecutive reactions consisting of the growthof cells, the DNA duplication, the distribution of chromosomes, the celldivision, and the like. Therefore, it is just conceivable that theexpression of various genes varies depending on each stage of the cellcycle. Further, it is considered that abnormality or disruption of thecell cycle is involved in numerous chronic diseases and oncogenesis(refer to Patent document 1). In addition, Patent document 1 discloses atechnique relative to a method of measuring the activity of a cell-cycleregulator and a method of diagnosing cancer using thereof.

Incidentally, when the luciferase gene is introduced into cells as areporter gene and the strength of expression of the luciferase gene isexamined using the luciferase activity as an indicator, the effect of atarget DNA fragment on the transcription of the luciferase gene can beexamined by linking the target DNA fragment to upstream or downstream ofthe luciferase gene. Further, a gene such as a transcription factor,considered to affect the transcription of luciferase gene, is linked toan expression vector and coexpressed with the luciferase gene, therebyenabling to examine the effect of a gene product of the gene on theexpression of the luciferase gene. In this regard, examples of themethod of introducing a reporter gene such as a luciferase gene intocells include a calcium phosphate method, a Lipofectin method, and anelectroporation method. Each method is used separately depending on thepurpose or the difference in the type of cell.

Further, the activity of the luciferase which is introduced into cellsand is expressed is measured (monitored) by the steps of reacting a celllysate in which the cells are dissolved with a substrate solutioncontaining luciferin, ATP, magnesium, or the like, and then quantifyingthe amount of luminescence from the cell lysate reacted with thesubstrate solution using a luminometer with a photomultiplier tube. Thatis, the luminescence is measured after dissolving the cells. Thus, theamount of expression of the luciferase genes at a certain point in timecan be measured as an average value of the whole cells.

In order to catch the amount of expression of luciferase genes withtime, it is necessary to measure the luminescence from living cellssequentially. The serial measurement of the luminescence from livingcells is performed by the steps of adding a luminometer function to anincubator for culturing cells, and then quantifying the amount ofluminescence from whole cell populations while culturing at regular timeintervals using a luminometer. This allows for measuring the expressionrhythm with a regular cycle, and the like. Thus, it is possible to catchchanges over time of the amount of expression of luciferase genes inwhole cells.

However, in the conventional reporter assay as described above, multiplecells at different stages of the cell cycle are mixed, so that the cellsat various stages have been handled as a group of data. Therefore, theoperation of synchronized culture is performed to match the stages ofthe cell cycle when the gene in connection with the cell cycle isanalyzed.

(III) Conventionally, a microscope apparatus that can observe a specimenby switching imaging magnification of a specimen image from a highmagnification mode to a low magnification mode, has commonly been used.With reference to such a microscope apparatus, there has been recentlyproposed a microscope apparatus in which a visual field of observationat low magnification is not limited by an objective lens with highmagnification and the overall image of a specimen can be grasped in awider visual field (for example, refer to Patent document 2). In themicroscope apparatus disclosed in Patent document 2, when a specimen isobserved at low magnification, the specimen image is formed using animaging lens for low magnification, in which the focal depth is deeperthan the conventional one, namely, NA (Numerical Aperture) on the sideof the specimen is smaller than the conventional one without theobjective lens with high magnification.

-   Patent document 1: Japanese Patent Application Laid-Open (JP-A) No.    2002-335997-   Patent document 2: JP-A No. 10-339845-   Non-patent document 1: H. J. Kennedy, A. E. Pouli, E. K.    Ainscow, L. S. Jouaville, R. Rizzuto, G. A. Rutter, “Glucose    generates sub-plasma membrane ATP microdomains in single islet    β-cells.”, Journal of Biological Chemistry, vol. 274, pp.    13281-13291, 1999

DISCLOSURE OF INVENTION Problem to be Solved by the Invention

(I) However, in the conventional technology, cells other than the cellswhose amount of luminescence is measured are used to determine whether aphotoprotein is localized at a predetermined site in cells or not.Additionally, since cells die when they are confirmed by a fluorescentantibody technique, it is not always known whether a photoprotein islocalized at a predetermined site in living cells which are subject tothe measurement of luminescence. Therefore, it is not necessarily clearthat the amount of luminescence from the cells is that from apredetermined site, which is a problem.

Particularly, when a gene is transiently introduced into cells, the geneis not introduced into all the cells. Thus, it is necessary to confirmwhether the gene has been introduced into the living cells themselveswhich are subject to the measurement of luminescence and whether aphotoprotein is localized at a predetermined site in the cells intowhich the gene has been introduced.

The present invention has been achieved in view of the above-mentionedproblems. An object of the present invention is to provide apredetermined site luminescence measuring method, and a predeterminedsite luminescence measuring apparatus, which allow for determiningwhether, when the luminescence from the predetermined site in livesamples is measured, a photoprotein is localized at the predeterminedsite in the same ones as the aforementioned samples.

(II) However, the operation of synchronized culture in the conventionaltechnology is complicated, which resulted in a heavy procedural burdenon experimenters.

The present invention has been achieved in view of the above-mentionedproblem. Another object of the present invention is to provide anexpression amount measuring method, in which when the amount ofexpression of genes which are introduced into cells for analysis ismeasured, the stage of the cell cycle can be identified withoutperforming the synchronized culture method, resulting in reducing theprocedural burden on experimenters.

(III) Meanwhile, in recent years, there has been a great need to observebiological cells by using GFP (Green Fluorescent Protein) or aluciferase gene, i.e. a bioluminescent enzyme, as a reporter ofexpression and labeling an intracellular predetermined site or afunctional protein with fluorescence or luminescence in research areas,such as cell biology and molecular biology. Usually, in order to catchtime-dependent change in expression in observing such cells, it isnecessary to continue to observe cells on the time series.

However, GFP is a protein which emits fluorescence depending onirradiation of excitation light and a specimen activated by GFP isirradiated with the excitation light with high intensity to givefluorescence. Thus, with reference to the observation using GFP, thespecimen is easily damaged and the observation is limited to about 1hour to 2 hours. Compared with this, in the observation using aluciferase gene, the observation can be performed for about several daysto several weeks because the luciferase gene is a self-luminous enzymeand does not damage a specimen. Thus, it is desired that continuousobservation using a luciferase gene is performed over time and thetime-dependent change in a specimen is caught by properly switching tothe observation using GFP depending on this result of the observationusing a luciferase gene.

However, the light emitted from the luciferase gene is very weak. Forthis reason, as for the observation of fluorescence, for example, whenobserving fluorescence from GFP, the weak luminescence from a luciferasegene cannot be observed using an imaging optical system with highmagnification to be used usually or a conventional imaging opticalsystem with low magnification in which both NA on the specimen side andNA on the image side are small. A microscope apparatus that combines theobservation of fluorescence and the observation of weak luminescence byweak luminescence has not been realized yet. Further, a microscopeapparatus that can immediately switch to the observation of fluorescencedepending on the result of continuous observation according to theobservation of weak luminescence has not been developed, either.

The present invention has been achieved in view of the abovecircumstances. Still another object of the present invention is toprovide a measuring apparatus which can switch between observation ofweak luminescence and observation of fluorescence properly and canswitch to the observation of fluorescence immediately depending on theresults of observation of weak luminescence.

Means for Solving Problem

To solve the above problems and to achieve the above objects, accordingto one aspect of the present invention, a predetermined siteluminescence measuring method measures the luminescence from a livesample into which a fusion gene is introduced, the fusion gene beingobtained by fusing a targeting base sequence that directs a photoproteinto a predetermined site in the sample and a luminescence-related genethat expresses the photoprotein, in order to obtain the amount ofluminescence from the predetermined site, wherein the fusion gene isobtained by further fusing a fluorescence-related gene that expresses afluorescence protein with the targeting base sequence, and theluminescence-related gene. The method includes a fluorescent imagecapturing step of capturing a fluorescent image of the sample into whichthe fusion gene is introduced, a determining step of determining whetherthe photoprotein is localized at the predetermined site based on thefluorescent image captured at the fluorescent image capturing step, anda luminescence measuring step of measuring the luminescence from thesample when the localization is determined as a result of thedetermining step.

According to another aspect of the present invention, the predeterminedsite luminescence measuring method further includes a luminescent imagecapturing step of, when multiple live samples into which the fusion geneis introduced are present in an area to be captured, capturing aluminescent image of the samples, and a selecting step of selecting asample for measurement from the samples in which the localization isdetermined as the result of the determining step by superimposing thefluorescent image captured at the fluorescent image capturing step andthe luminescent image captured at the luminescent image capturing step,wherein the fluorescent image capturing step includes capturing thefluorescent image of the samples, the determining step includesdetermining whether the photoprotein is localized at the predeterminedsite based on the fluorescent image for each sample, and theluminescence measuring step includes measuring the luminescence from thesample selected at the selecting step.

According to still another aspect of the present invention, in thepredetermined site luminescence measuring method, the amount ofluminescence from the predetermined site in the sample is obtainedsequentially by repeatedly performing the fluorescent image capturingstep, the determining step, the luminescent image capturing step, theselecting step, and the luminescence measuring step.

According to still another aspect of the present invention, thepredetermined site luminescence measuring method further includes aluminescence separation step of separating luminescence from the samplein accordance with luminescent color, wherein multiple fusion genes tobe introduced into the samples are prepared in advance so that eachcombination of a targeted site to which the photoprotein is directed bythe targeting base sequence, a luminescent color of luminescence emittedfrom the photoprotein, and a fluorescent color of fluorescence emittedfrom the fluorescence protein is different, the determining stepincludes determining whether a photoprotein is localized at thepredetermined site for each fluorescent color based on the fluorescentimage, and the luminescence measuring step includes, when thelocalization is determined as a result of the determining step,specifying luminescence from the site where the localization isdetermined among the multiple luminescence separated at the luminescenceseparation step, and measuring the specified luminescence.

According to still another aspect of the present invention, in thepredetermined site luminescence measuring method, the sample is any oneof a test sample, a tissue, a cell, and an individual.

According to still another aspect of the present invention, thepredetermined site luminescence measuring method further includes an ATPquantifying step of quantifying ATP at the predetermined site in thesamples selected at the selecting step based on the amount ofluminescence measured at the luminescence measuring step, wherein thesample is a cell, the predetermined site is mitochondria, the targetingbase sequence is a mitochondrial targeting signal, the photoprotein isluciferase, and the fluorescence protein is a green fluorescent protein,and ATP at the predetermined site in the sample is quantifiedsequentially by repeatedly performing the fluorescent image capturingstep, the determining step, the luminescent image capturing step, theselecting step, the luminescence measuring step, and the ATP quantifyingstep.

According to still another aspect of the present invention, apredetermined site luminescence measuring apparatus measures theluminescence from a live sample into which a fusion gene is introduced,the fusion gene being obtained by fusing a targeting base sequence thatdirects a photoprotein to a predetermined site in the sample and aluminescence-related gene that expresses the photoprotein, in order toobtain the amount of luminescence from the predetermined site, whereinthe fusion gene obtained by further fusing a fluorescence-related genethat expresses a fluorescence protein with the targeting base sequence,and the luminescence-related gene. The apparatus includes a fluorescentimage capturing unit that captures a fluorescent image of the sampleinto which the fusion gene is introduced, a determining unit thatdetermines whether the photoprotein is localized at the predeterminedsite based on the fluorescent image captured by the fluorescent imagecapturing unit, and a luminescence measuring unit that measures theluminescence from the sample when the localization is determined as aresult of the determining unit.

According to still another aspect of the present invention, anexpression amount measuring method includes a luminescence measuringstep of measuring luminescence intensity of luminescence emitted from aliving cell into which a luminescence-related gene which expresses aphotoprotein, a fluorescence-related gene which expresses a fluorescenceprotein, and a gene to be analyzed are introduced, a fluorescencemeasuring step of measuring fluorescence intensity emitted from thecell, and an expression amount measuring step of measuring the amount ofexpression of the gene to be analyzed based on the luminescenceintensity measured at the luminescence measuring step or thefluorescence intensity measured at the fluorescence measuring step,wherein the cell is a cell into which a cell cycle-related gene whichexpresses at a predetermined stage of the cell cycle is furtherintroduced in addition to the luminescence-related gene, thefluorescence-related gene, and the gene to be analyzed. The methodfurther includes a stage identifying step of identifying the stage ofthe cell cycle by determining the presence or absence of the expressionof the cell cycle-related gene based on the fluorescence intensitymeasured at the fluorescence measuring step when the luminescenceintensity is used at the expression amount measuring step, or based onthe luminescence intensity measured at the luminescence measuring stepwhen the fluorescence intensity is used at the expression amountmeasuring step.

According to still another aspect of the present invention, theexpression amount measuring method further includes a fluorescent imagecapturing step of, when multiple cells are present in an area to becaptured, capturing a fluorescent image of the cells, and a luminescentimage capturing step of capturing a luminescent image of the cells,wherein the luminescence measuring step includes measuring luminescenceintensity of luminescence emitted from each cell based on theluminescent image captured at the luminescent image capturing step, thefluorescence measuring step includes measuring fluorescence intensityemitted from each cell based on the fluorescent image captured at thefluorescent image capturing step, the expression amount measuring stepincludes measuring the amount of expression of the gene to be analyzedin each cell based on the luminescence intensity measured at theluminescence measuring step or the fluorescence intensity measured atthe fluorescence measuring step, and the stage identifying stepidentifies the stage of the cell cycle for each cell by determining thepresence or absence of the expression of the cell cycle-related gene foreach cell based on the fluorescence intensity measured at thefluorescence measuring step when the luminescence intensity is used atthe expression amount measuring step, or based on the luminescenceintensity measured at the luminescence measuring step when thefluorescence intensity is used at the expression amount measuring step.

According to still another aspect of the present invention, theexpression amount measuring method further includes a selecting step ofselecting the cell for measurement from among the cells whose stages areidentified at the stage identifying step, wherein the expression amountmeasuring step includes measuring the amount of expression of the geneto be analyzed which is introduced into the cells selected at theselecting step, based on the luminescence intensity measured at theluminescence measuring step or the fluorescence intensity measured atthe fluorescence measuring step.

According to still another aspect of the present invention, in theexpression amount measuring method, the amount of expression of the geneto be analyzed is measured sequentially by repeatedly performing theluminescent image capturing step, the fluorescent image capturing step,the luminescence measuring step, the fluorescence measuring step, thestage identifying step, the selecting step, and the expression amountmeasuring step while the stage of the cell cycle is identified in thecells selected at the selecting step.

According to still another aspect of the present invention, in theexpression amount measuring method, the expression amount measuring stepincludes measuring the amount of expression of the gene to be analyzedin the cell selected at the selecting step based on the fluorescenceintensity measured at the fluorescence measuring step, and identifyingan expression site of the gene to be analyzed in the cell based on thefluorescent image captured at the fluorescent image capturing step.

According to still another aspect of the present invention, anexpression amount measuring method includes a luminescence measuringstep of measuring luminescence intensity of luminescence emitted fromcells in a living cell into which a luminescence-related gene whichexpresses a photoprotein and a gene to be analyzed are introduced, andan expression amount measuring step of measuring the amount ofexpression of the gene to be analyzed based on the luminescenceintensity measured at the luminescence measuring step, wherein the cellis stained with a fluorescent substance at the predetermined site. Themethod further includes a fluorescent image capturing step of capturinga fluorescent image of the cell; and a stage identifying step ofidentifying the stage of the cell cycle by determining whether the shapeof the cell is changed or not based on the fluorescent image captured atthe fluorescent image capturing step.

According to still another aspect of the present invention, theexpression amount measuring method further includes a luminescent imagecapturing step of, when multiple cells are present in an area to becaptured, capturing a luminescent image of the cells, wherein thefluorescent image capturing step includes capturing a fluorescent imageof the cells, the luminescence measuring step includes measuringluminescence intensity of luminescence emitted from each cell based onthe luminescent image captured at the luminescent image capturing step,the expression amount measuring step includes measuring the amount ofexpression of the gene to be analyzed in each cell based on theluminescence intensity measured at the luminescence measuring step, andthe stage identifying step includes identifying the stage of the cellcycle by determining whether the shape of the cell is changed or notbased on the fluorescent image captured at the fluorescent imagecapturing step.

According to still another aspect of the present invention, theexpression amount measuring method further includes a selecting step ofselecting the cell for measurement from among the cells whose stages areidentified at the stage identifying step, wherein the expression amountmeasuring step includes measuring the amount of expression of the geneto be analyzed which is introduced into cells selected at the selectingstep, based on the luminescence intensity measured at the luminescencemeasuring step.

According to still another aspect of the present invention, in theexpression amount measuring method, the amount of expression of the geneto be analyzed is measured sequentially by repeatedly performing theluminescent image capturing step, the fluorescent image capturing step,the luminescence measuring step, the stage identifying step, theselecting step, and the expression amount measuring step while the stageof the cell cycle is identified in the cells selected at the selectingstep.

According to still another aspect of the present invention, a measuringapparatus includes an imaging optical system which forms a specimenimage of a specimen which is labeled with a luminescent label emittingweak luminescence or a fluorescent label emitting fluorescence byexcitation and held by a holding unit; and a capturing unit thatcaptures the specimen image, wherein the imaging optical system includesa weak luminescence imaging optical system that forms the specimen imageof weak luminescence from the luminescent label as a weak luminescentspecimen image; and a fluorescence imaging optical system that forms thespecimen image of fluorescence from the fluorescent label as afluorescent specimen image, and the capturing unit captures the weakluminescent specimen image and the fluorescent specimen image.

According to still another aspect of the present invention, in themeasuring apparatus, the fluorescence imaging optical system comprisesan illuminating unit that illuminates the specimen.

According to still another aspect of the present invention, themeasuring apparatus includes an image capture switch controlling unitthat makes a control to switch between the capturing of the weakluminescent specimen image and the capturing of the fluorescent specimenimage, based on an image characteristic of the weak luminescent specimenimage captured by the capturing unit.

According to still another aspect of the present invention, in themeasuring apparatus, the image characteristic is image intensity of theweak luminescent specimen image, and the image capture switchcontrolling unit switches from the capturing of the weak luminescentspecimen image to the capturing of the fluorescent specimen image whenthe image intensity is higher than a predetermined threshold.

According to still another aspect of the present invention, in themeasuring apparatus, the image intensity is the image intensity of allor part of the weak luminescent specimen image, and is cumulative imageintensity from a predetermined time point up to a current time point orcurrent image intensity.

According to still another aspect of the present invention, in themeasuring apparatus, the fluorescence imaging optical system includes afluorescence objective lens that converts fluorescence from each pointof the fluorescent label into a substantially parallel pencil of rays, afluorescence imaging lens that concentrates the fluorescence convertedinto the substantially parallel pencil of rays by the fluorescenceobjective lens to form the fluorescent specimen image, a fluorescenceunit including: an excitation light transmitting filter whichselectively transmits excitation light that excites the fluorescentlabel; a fluorescence transmitting filter which selectively transmitsthe fluorescence from the fluorescent label; and a dichroic mirror whichreflects the excitation light and transmits the fluorescence, thefluorescence unit being arranged between the fluorescence objective lensand the fluorescence imaging lens, and an excitation light irradiatingunit including an excitation light source that emits the excitationlight, the excitation light irradiating unit reflecting the excitationlight from the excitation light source by the dichroic mirror toirradiate the specimen with the excitation light.

According to still another aspect of the present invention, in themeasuring apparatus, the weak luminescence imaging optical systemincludes a weak luminescence objective lens that converts weakluminescence from each point of the luminescent label into asubstantially parallel pencil of rays, and a weak luminescence imaginglens that concentrates the weak luminescence converted into thesubstantially parallel pencil of rays by the weak luminescence objectivelens to form the weak luminescent specimen image.

According to still another aspect of the present invention, in themeasuring apparatus, the weak luminescence imaging optical system andthe fluorescence imaging optical system are mutually arranged on theopposite sides across the specimen, the excitation light irradiatingunit includes a non-irradiating unit that does not irradiate thespecimen with excitation light, and the image capture switch controllingunit controls the non-irradiating unit not to irradiate the specimenwith excitation light when causing the capturing unit to capture a weakluminescent specimen, and controls the excitation light irradiating unitto irradiate the specimen with excitation light when causing thecapturing unit to capture a fluorescent specimen image.

According to still another aspect of the present invention, themeasuring apparatus includes a visual field moving unit that moves thevisual fields of the weak luminescence imaging optical system and thefluorescence imaging optical system relatively and parallel to eachother.

According to still another aspect of the present invention, in themeasuring apparatus, the holding unit includes a specimen transferringunit that transfers the specimen to each visual field of the weakluminescence imaging optical system and the fluorescence imaging opticalsystem.

According to still another aspect of the present invention, in themeasuring apparatus, the weak luminescence objective lens and thefluorescence objective lens are the same lens, and the weak luminescenceimaging optical system and the fluorescence imaging optical system sharethe objective lens.

According to still another aspect of the present invention, themeasuring apparatus further includes a mirror which is insertably anddetachably arranged in a pupil space between the objective lens and thefluorescence unit, the mirror reflecting weak luminescence from theobjective lens to the weak luminescence imaging lens when arranged inthe pupil space, wherein the excitation light irradiating unit includesa non-irradiation unit that does not irradiate the specimen withexcitation light, and the image capture switch controlling unit arrangesthe mirror in the pupil space and controls the non-irradiating unit notto irradiate with excitation light when causing the capturing unit tocapture a weak luminescent specimen image, and arrange the mirror out ofthe pupil space and controls the excitation light irradiating unit toirradiate with excitation light when causing the capturing unit tocapture a fluorescent specimen image.

According to still another aspect of the present invention, in themeasuring apparatus, the weak luminescence imaging optical system andthe fluorescence imaging optical system are arranged on the same sidewith respect to the specimen, the holding unit includes a specimentransferring unit that transfers the specimen to each visual field ofthe weak luminescence imaging optical system and the fluorescenceimaging optical system, and the image capture switch controlling unitcontrols the specimen transferring unit to transfer the specimen to thevisual field of the weak luminescence imaging optical system whencausing the capturing unit to capture a weak luminescent specimen image,and controls the specimen transferring unit to transfer the specimen tothe visual field of the fluorescence imaging optical system when causingthe capturing unit to capture a fluorescent specimen image.

According to still another aspect of the present invention, themeasuring apparatus further includes an optical system moving unit thatmoves the weak luminescence imaging optical system and the fluorescenceimaging optical system so that the visual fields of the weakluminescence imaging optical system and the fluorescence imaging opticalsystem cover the specimen, wherein the weak luminescence imaging opticalsystem and the fluorescence imaging optical system are arranged on thesame side with respect to the specimen, and the image capture switchcontrolling unit controls the optical system moving unit to move theweak luminescence imaging optical system so that the visual field of theweak luminescence imaging optical system covers the specimen whencausing the capturing unit to capture a weak luminescent specimen image,and controls the optical system moving unit to move the fluorescenceimaging optical system so that the visual field of the fluorescenceimaging optical system covers the specimen when causing the capturingunit to capture a fluorescent specimen image.

According to still another aspect of the present invention, in themeasuring apparatus, the optical system moving unit includes an axis ofrotation that passes through the midpoint of a line segment connectingsubstantially central points of the visual fields of the weakluminescence imaging optical system and the fluorescence imaging opticalsystem and is substantially parallel to the optical axis of each of theweak luminescence imaging optical system and the fluorescence imagingoptical system, the optical system moving unit rotating and moving theweak luminescence imaging optical system and the fluorescence imagingoptical system around the axis of rotation.

According to still another aspect of the present invention, in themeasuring apparatus, the capturing unit includes a weak luminescencecapturing unit that captures the weak luminescent specimen image, and afluorescence capturing unit that captures the fluorescent specimenimage.

According to still another aspect of the present invention, in themeasuring apparatus, the capturing unit includes a weak luminescencecapturing unit that captures the weak luminescent specimen image, and afluorescence capturing unit that captures the fluorescent specimenimage, and the optical system moving unit integrally moves the weakluminescence imaging optical system and the weak luminescence capturingunit as well as the fluorescence imaging optical system and thefluorescence capturing unit.

According to still another aspect of the present invention, in themeasuring apparatus, the weak luminescent specimen image and thefluorescent specimen image are formed in substantially the same positionby the weak luminescence imaging lens and the fluorescence imaging lens,respectively, and the capturing unit is fixed in a positionsubstantially corresponding to the position where the weak luminescentspecimen image and the fluorescent specimen image are formed.

According to still another aspect of the present invention, themeasuring apparatus further includes an illuminating unit thatcorresponds to at least one of the weak luminescence imaging opticalsystem and the fluorescence imaging optical system, for transmitillumination to the specimen.

According to still another aspect of the present invention, in themeasuring apparatus, the transmitted illumination is at least one ofillumination for bright field observation, illumination for dark fieldobservation, illumination for differential interference observation, andillumination for phase contrast observation.

According to still another aspect of the present invention, in themeasuring apparatus, the weak luminescence imaging optical system has avalue calculated by (NAo/β)² of 0.01 or more, where NAo is a numericalaperture on the side of the specimen of the weak luminescence imagingoptical system, and β is a magnification for forming the weakluminescent specimen image.

EFFECT OF THE INVENTION

(I) According to the present invention, a method or an apparatus obtainsthe amount of luminescence at a predetermined site by measuring theluminescence from a live sample into which a fusion gene is introduced,the fusion gene being obtained by fusing a targeting base sequence thatdirects a photoprotein to the predetermined site in the sample and aluminescence-related gene which expresses the photoprotein. The fusiongene is obtained by further fusing a fluorescence-related gene whichexpresses a fluorescence protein with the targeting base sequence, andthe luminescence-related gene. The method or the apparatus includes thesteps of capturing a fluorescent image of the sample into which thefusion gene is introduced, determining whether the photoprotein islocalized at the predetermined site based on the captured fluorescentimage, and measuring the luminescence from the sample when thelocalization is determined as the determined result. This allows fordetermining whether, when the luminescence from the predetermined sitein the live sample is measured, the photoprotein is localized at thepredetermined site in the sample itself.

According to another aspect of the present invention, the method or theapparatus includes, when live samples into which the fusion gene isintroduced are present in an area to be captured, capturing afluorescent image of the samples, determining whether the photoproteinis localized at the predetermined site in each sample based on thefluorescent image, capturing a luminescent image of the samples,selecting a sample for measurement from the samples in which thelocalization is determined by superimposing the captured fluorescentimage and the captured luminescent image, and measuring the luminescencefrom the selected sample. This produces an effect that individualsamples are distinguished from one another and the luminescence from thepredetermined site can be measured in a single sample.

According to the present invention, the amount of luminescence from thepredetermined site in the sample is obtained sequentially by repeatedlyperforming the capture of a fluorescent image, the determination of thelocalization, the capture of a luminescent image, the selection of thesample for measurement, and the measurement of the luminescence. Thisproduces an effect that changes in luminescence at the predeterminedsite in a sample can be measured sequentially.

According to the present invention, fusion genes to be introduced intothe samples are prepared in advance so that each combination of atargeted site to which the photoprotein is directed by the targetingbase sequence, a luminescent color of luminescence emitted from thephotoprotein, and a fluorescent color of fluorescence emitted from thefluorescence protein is different. The method or the apparatus includesseparating luminescence from the sample in accordance with luminescentcolor, determining whether the photoprotein is localized at thepredetermined site for each fluorescent color, specifying luminescencefrom the site where the localization is determined among the multipleluminescence separated when the localization is determined as thedetermined result, and measuring the specified luminescence. Forexample, this produces an effect in which the luminescence from multiplesites in one sample can be measured at the same time.

According to the present invention, the sample is any one of a tissue, acell, and an individual, which allows for using various samples.

According to the present invention, the sample is a cell, thepredetermined site is mitochondria, the targeting base sequence is amitochondrial targeting signal, the photoprotein is luciferase, and thefluorescence protein is a green fluorescent protein. ATP at thepredetermined site in the selected sample is quantified based on themeasured amount of luminescence, and then the amount of ATP at thepredetermined site in the samples is quantified sequentially byrepeatedly performing the capture of a fluorescent image, thedetermination of the localization, the capture of a luminescent image,the selection of the sample for measurement, the measurement of theluminescence, and further quantification of ATP. This produces an effectthat changes of the amount of ATP in mitochondria of a particular cellcan be measured sequentially.

(II) According to the present invention, in living cells into which aluminescence-related gene which expresses a photoprotein, afluorescence-related gene which expresses a fluorescence protein, and agene to be analyzed are introduced, luminescence intensity ofluminescence emitted from the cells is measured, fluorescence intensityemitted from the cells is measured, and the amount of expression of thegene to be analyzed is measured based on the measured luminescenceintensity or the measured fluorescence intensity. The cell is a cellinto which a cell cycle-related gene which is expressed at apredetermined stage of the cell cycle is introduced in addition to theluminescence-related gene, the fluorescence-related gene, and the geneto be analyzed. A stage of the cell cycle is identified by determiningwhether the cell cycle-related gene is expressed or not based on themeasured fluorescence intensity when luminescence intensity is used tomeasure the amount of expression, and the measured luminescenceintensity when fluorescence intensity is used to measure the amount ofexpression. This produces an effect that when the amount of expressionof the gene to be analyzed introduced into cells is measured, stages ofthe cell cycle can be identified in the cell without performing thesynchronized culture method, resulting in reducing the procedural burdenon experimenters. Further, this produces an effect in which therelationship between the gene to be analyzed and the stage of the cellcycle can be evaluated for each cell. Specifically, this produces aneffect in which as for the gene to be analyzed whose direct involvementin the cell cycle is unknown, it is possible to obtain change inexpression which is caused by administration of a medicine ortemperature changes, and the stage of the cell cycle, which allows forverifying the relation between the gene to be analyzed and the cellcycle. Further, this produces an effect in which as for the gene to beanalyzed considered to be directly involved in the cell cycle, both theamount of expression of the gene to be analyzed and the stage of thecell cycle can be obtained, thereby enabling to evaluate whether thegene to be analyzed is useful as a cell-cycle marker.

According to the present invention, when multiple cells are present inan area to be captured, a fluorescent image of the cells is captured anda luminescent image of the cells is captured. Luminescence intensity ofluminescence emitted from each cell is measured based on the capturedluminescent image, and fluorescence intensity emitted from each cell ismeasured based on the captured fluorescent image, so that the amount ofexpression of gene to be analyzed in each cell is measured based on themeasured luminescence intensity or the measured fluorescence intensity.The stage of the cell cycle is identified by determining whether thecell cycle-related gene is expressed in each cell based on the measuredfluorescence intensity when luminescence intensity is used to measurethe amount of expression, and on the measured luminescence intensitywhen fluorescence intensity is used to measure the amount of expression.This produces an effect that the amount of expression of the gene to beanalyzed in each cell of the cells can be measured, and the stage of thecell cycle can be identified for each cell. Further, this produces aneffect in which the relationship between the gene to be analyzed and thestage of the cell cycle can be evaluated for each cell.

According to the present invention, the cells for measurement areselected from among the cells whose stage is identified and the amountof expression of the gene to be analyzed introduced into the selectedcells is measured based on the measured luminescence intensity or themeasured fluorescence intensity. This produces an effect that individualcells are distinguished from one another to measure the amount ofexpression of the gene to be analyzed in a single cell, and the stage ofthe cell cycle can be identified.

According to the present invention, the amount of expression of the geneto be analyzed is measured sequentially by repeatedly performing thecapture of a luminescent image, the capture of a fluorescent image, themeasurement of luminescence intensity, the measurement of fluorescenceintensity, the identification of the stage, the selection of cells, andthe measurement of the amount of expression while the stage of the cellcycle is identified in the selected cells. This produces an effect thatchange in expression of the gene to be analyzed can be measuredsequentially in a single cell while the stage of the cell cycle isidentified.

According to the present invention, in measurement of the amount ofexpression, the amount of expression of the gene to be analyzed ismeasured in the selected cell based on the measured fluorescenceintensity, and a site of the expression of the gene to be analyzed inthe cell is identified based on the captured fluorescent image. Thisproduces an effect which allows for not only the evaluation of therelationship between the gene to be analyzed and the stage of the cellcycle, but also the identification of a site of the expression of thegene to be analyzed in a cell.

Further, according to the present invention, in living cells into whicha luminescence-related gene which expresses a photoprotein and a gene tobe analyzed are introduced, luminescence intensity of luminescenceemitted from the cells is measured, and the amount of expression of thegene to be analyzed is measured on the basis of the measuredluminescence intensity. The cell is stained with a fluorescent substanceat the predetermined site (specifically, nucleus, cell membrane,cytoplasm, etc.), a fluorescent image of the cell is captured, and thestage of the cell cycle is identified by determining whether the shapeof a cell is changed or not based on the captured fluorescent image.This produces an effect that when the amount of expression of the geneto be analyzed introduced into cells is measured, the stage of the cellcycle can be identified in the cells without performing the synchronizedculture method, resulting in reducing the procedural burden onexperimenters. Further, this produces an effect in which therelationship between the gene to be analyzed and the stage of the cellcycle can be evaluated. Specifically, this produces an effect in whichas for the gene to be analyzed whose direct involvement in the cellcycle is unknown, change in expression which is caused by administrationof a medicine or temperature changes can be obtained in addition to thestage of the cell cycle, which allows for verifying the relation betweenthe gene to be analyzed and the cell cycle. Further, this produces aneffect in which as for the gene to be analyzed considered to be directlyinvolved in the cell cycle, both the amount of expression of the gene tobe analyzed and the stage of the cell cycle can be obtained, therebyenabling to evaluate whether the gene to be analyzed is useful as acell-cycle marker or not.

According to the present invention, when cells are present in an area tobe captured, a luminescent image of the cells is captured, and afluorescent image of the cells is captured. Luminescence intensity ofluminescence emitted from each cell is measured based on the capturedluminescent image, and the amount of expression of gene to be analyzedin each cell is measured based on the measured luminescence intensity.The stage of the cell cycle is identified by determining whether theshape of the cell is changed or not based on the captured fluorescentimage. This produces an effect that the amount of expression of the geneto be analyzed in each of the cells is measured and the stage of thecell cycle can be identified for each cell. Further, this produces aneffect in which the relationship between the gene to be analyzed and thestage of the cell cycle can be evaluated for each cell.

According to the present invention, the cells for measurement areselected from among the cells whose stages are identified, and theamount of expression of gene to be analyzed introduced into the selectedcells is measured based on the measured luminescence intensity. Thisproduces an effect that individual cells are distinguished from oneanother, the amount of expression of the gene to be analyzed is measuredin a single cell, and the stage of the cell cycle can be identified.

According to the present invention, the amount of expression of gene tobe analyzed is measured sequentially by repeatedly performing thecapture of a luminescent image, the capture of a fluorescent image, themeasurement of luminescence intensity, the identification of the stage,the selection of cells, and the measurement of the amount of expressionwhile the stage of the cell cycle is identified in the selected cells.This produces an effect that change in expression of the gene to beanalyzed can be measured sequentially in a single cell while the stageof the cell cycle is identified.

(III) In the measuring apparatus according to the present invention, theobservation of weak luminescence and fluorescence can be individuallyperformed for the same specimen held by the holding unit and theobservation of weak luminescence can be switched to the observation offluorescence immediately depending on the results of the observation ofweak luminescence.

BRIEF DESCRIPTION OF DRAWINGS

FIG. 1 is a diagram of an example of the entire configuration of apredetermined site luminescence measuring apparatus 100;

FIG. 2 is a diagram of an example of the configuration of a luminescentimage capturing unit 106 of the predetermined site luminescencemeasuring apparatus 100;

FIG. 3 is a diagram of another example of the configuration of theluminescent image capturing unit 106 of the predetermined siteluminescence measuring apparatus 100;

FIG. 4 is a block diagram of an example of the configuration of aninformation communication terminal 110 of the predetermined siteluminescence measuring apparatus 100;

FIG. 5 is a flow chart of an example of a processing that is performedby the predetermined site luminescence measuring apparatus 100;

FIG. 6 is a view of an example of a bright-field image and a fluorescentimage captured by a fluorescent image capturing unit 108;

FIG. 7 is a view of an example of a bright-field image and a luminescentimage captured by a luminescent image capturing unit 106;

FIG. 8 is a view of an example of overlapped images captured by theluminescent image capturing unit 106 and the fluorescent image capturingunit 108 in chronological order;

FIG. 9 is a graph of an example of changes over time in luminescenceintensity of a specified cell;

FIG. 10 is a view of a plasmid vector fused with GFP, a mitochondrialtargeting signal, and luciferase;

FIG. 11 is a view of a bright-field image and a fluorescent image of aHeLa cell into which the plasmid vector is introduced, which arecaptured by the fluorescent image capturing unit 108;

FIG. 12 is a view of a bright-field image and a luminescent image of aHeLa cell into which the plasmid vector is introduced, which arecaptured by the luminescent image capturing unit 106;

FIG. 13 is a graph of an example of changes over time in luminescenceintensity of a specified HeLa cell;

FIG. 14 is a diagram of an example of the entire configuration of thepredetermined site luminescence measuring apparatus 100;

FIG. 15 is a diagram of an example of the entire configuration of thepredetermined site luminescence measuring apparatus 100;

FIG. 16 is a diagram of an example of the entire configuration of thepredetermined site luminescence measuring apparatus 100;

FIG. 17 is a view of a fluorescent image of a HeLa cell into which anEGFP-Luc gene is introduced;

FIG. 18 is a view of an image obtained by overlapping a bright-fieldimage and the fluorescent image of the HeLa cell into which the EGFP-Lucgene is introduced;

FIG. 19 is a view of a luminescent image of the HeLa cell into which anEGFP-Luc gene is introduced;

FIG. 20 is a diagram of an example of the entire configuration of anexpression amount measuring apparatus 1000;

FIG. 21 is a diagram of an example of the configuration of a luminescentimage capturing unit 1060 of the expression amount measuring apparatus1000;

FIG. 22 is a diagram of another example of the configuration of theluminescent image capturing unit 1060 of the expression amount measuringapparatus 1000;

FIG. 23 is a block diagram of an example of the configuration of aninformation communication terminal 1100 of the expression amountmeasuring apparatus 1000;

FIG. 24 is a flow chart of an example of a processing that is performedby the expression amount measuring apparatus 1000;

FIG. 25 is a diagram of the configuration of a microscope apparatusaccording to a first embodiment of the present invention;

FIG. 26 is a flow chart of the procedure for an image switchingprocessing in which the microscope apparatus shown in FIG. 25 switchesbetween observation of weak luminescence and observation offluorescence;

FIG. 27 is a diagram of the configuration of a microscope apparatusaccording to a second embodiment of the present invention;

FIG. 28 is a diagram of the configuration of a modification of themicroscope apparatus according to the second embodiment of theinvention;

FIG. 29 is a diagram of the configuration of a microscope apparatusaccording to a third embodiment of the present invention;

FIG. 30 is a diagram of the configuration of a microscope apparatusaccording to a fourth embodiment of the present invention;

FIG. 31 is a diagram of the configuration of a microscope apparatusaccording to a fifth embodiment of the present invention;

FIG. 32 is a diagram of the configuration of a modification of themicroscope apparatus according to the fifth embodiment of the invention;

FIG. 33 is a diagram of the configuration of a modification of themicroscope apparatus according to the fifth embodiment of the invention;and

FIG. 34 is a diagram of the configuration of a modification of themicroscope apparatus according to the fifth embodiment of the invention.

EXPLANATIONS OF LETTERS OR NUMERALS

-   -   100 predetermined site luminescence measuring apparatus    -   102 sample    -   103 container    -   104 stage    -   106 luminescent image capturing unit        -   106 a objective lens (for observation of luminescence)        -   106 b dichroic mirror        -   106 c CCD camera        -   106 d split image unit        -   106 e filter wheel        -   106 f imaging lens    -   108 fluorescent image capturing unit        -   108 a objective lens (for observation of fluorescence)        -   108 b dichroic mirror        -   108 c light source        -   108 d CCD camera        -   108 e imaging lens        -   108 f shutter        -   108 g spectral filter for excitation        -   108 h optical fiber        -   108 i condenser lens        -   108 j filter for luminescence and fluorescence spectra    -   110 information communication terminal        -   112 controlling unit            -   112 a fluorescent image capture instructing unit            -   112 b fluorescent image acquiring unit            -   112 c determining unit            -   112 d luminescent image capture instructing unit            -   112 e luminescent image acquiring unit            -   112 f selecting unit            -   112 g luminescence measuring unit            -   112 h related substance quantifying unit        -   114 clock generating unit        -   116 storage unit        -   118 communication interface unit        -   120 input/output interface unit        -   122 input unit        -   124 output unit    -   1000 expression amount measuring apparatus        -   1020 cell        -   1030 container        -   1040 stage        -   1060 luminescent image capturing unit            -   1060 a objective lens (for observation of luminescence)            -   1060 b dichroic mirror            -   1060 c CCD camera            -   1060 d split image unit            -   1060 e filter wheel        -   1080 fluorescent image capturing unit            -   1080 a objective lens (for observation of fluorescence)            -   1080 b dichroic mirror            -   1080 c xenon lamp            -   1080 d CCD camera        -   1100 information communication terminal        -   1120 controlling unit            -   1120 a fluorescent image capture instructing unit            -   1120 b luminescent image capture instructing unit            -   1120 c fluorescent image acquiring unit            -   1120 d luminescent image acquiring unit            -   1120 e determining unit            -   1120 f fluorescence measuring unit            -   1120 g luminescence measuring unit            -   1120 h stage identifying unit            -   1120 i selecting unit            -   1120 j expression measuring unit        -   1140 clock generating unit        -   1160 storage unit        -   1180 communication interface unit        -   1200 input/output interface unit        -   1220 input unit    -   1, 11 objective lens    -   2, 12, 32 imaging lens    -   3, 13 imaging device    -   4 excitation light source    -   5 lens    -   6 fluorescence cube    -   6 a excitation filter    -   6 b absorption filter    -   6 c dichroic mirror    -   7, 17 holding unit    -   7 a holding member    -   7 b, 17 b movable stage    -   8, 18 stage driving unit    -   9 monitor    -   14 rotary drive unit    -   15 a, 15 b fixed shaft    -   21, 22, 23, 24, 25, 26 casing    -   33, 43 shutter    -   34 mirror    -   35 optical path switch driving unit    -   44 white light source    -   45 illuminating lens system    -   45 a collector lens    -   45 b condenser lens    -   46 illumination driving unit    -   100 a, 200, 300, 400, 500, 600, 700, 800, 900 microscope        apparatus    -   101, 201 fluorescence microscope unit    -   102 a, 202 weak luminescence microscope unit    -   103 a transmitted illumination unit    -   104 a, 105 fluorescent lighting unit    -   PC1˜PC9 controlling apparatus    -   S specimen

BEST MODES FOR CARRYING OUT THE INVENTION

(I) Hereinbelow, embodiments of a predetermined site luminescencemeasuring method and a predetermined site luminescence measuringapparatus in the present invention will be described in detail on thebasis of the drawings. However, the present invention is not limited bythese embodiments.

First, the configuration of a predetermined site luminescence measuringapparatus 100 that realizes the present invention will be described withreference to FIGS. 1 to 3. FIG. 1 is a diagram of an example of theentire configuration of the predetermined site luminescence measuringapparatus 100.

As shown in FIG. 1, the predetermined site luminescence measuringapparatus 100 includes a sample 102, a container 103 accommodating thesample 102 (specifically, a petri dish, a slide glass, a microplate, agel supporting matrix, particulate carriers, etc.), a stage 104 on whichthe container 103 is arranged, a luminescent image capturing unit 106, afluorescent image capturing unit 108, and an information communicationterminal 110. In the predetermined site luminescence measuring apparatus100, as shown in the figure, an objective lens 106 a included in theluminescent image capturing unit 106 and an objective lens 108 aincluded in the fluorescent image capturing unit 108 are arranged invertically opposed positions across the sample 102, the container 103,and the stage 104. As shown in FIG. 14, the arrangement of theluminescent image capturing unit 106 and the fluorescent image capturingunit 108 may be replaced. Disturbance light from upper side of thesample which is caused by opening and closing a cover can be completelyblocked by placing the luminescent image capturing unit 106 formeasuring luminescence that is weaker than fluorescence on the downside,and an S/N ratio of a luminescent image can be increased. Thefluorescent image capturing unit 108 that is a separate body from theluminescent image capturing unit 106 may be a laser scanning opticalsystem.

Referring to FIG. 1 again, the sample 102 is a sample into which afusion gene is introduced. The fusion gene is obtained by fusing atargeting base sequence that directs a photoprotein to a predeterminedsite (for example, mitochondria or cytoplasm, nucleus) in the sample102, a luminescence-related gene that expresses the photoprotein, and afluorescence-related gene that expresses a fluorescence protein. Thesample 102 is a living sample such as a test sample, a tissue, a cell,and an individual. Specifically, the sample 102 may be a sample intowhich a plasmid vector containing the fusion gene is introduced.

The luminescent image capturing unit 106 is specifically an uprightluminescence microscope and captures a luminescent image of the sample102. As shown in the figure, the luminescent image capturing unit 106includes an objective lens 106 a, a dichroic mirror 106 b, a CCD camera106 c, and an imaging lens 106 f. Specifically, the objective lens 106 ahas a value not less than 0.01 found by (NumericalAperture/magnification)². The dichroic mirror 106 b is used to separatethe luminescence emitted from the sample 102 according to color andmeasures the amount of the luminescence according to color usingtwo-color luminescence. The CCD camera 106 c captures the luminescentimage and bright-field image of the sample 102 that are projected on thechip surface of the CCD camera 106 c through the objective lens 106 a,the dichroic mirror 106 b, and the imaging lens 106 f. The CCD camera106 c is connected to the information communication terminal 110 toenable either wired or wireless communication. Here, when samples 102are present in an area to be captured, the CCD camera 106 c may capturethe luminescent image and bright-field image of the samples 102 that arein the area to be captured. The imaging lens 106 f forms an image(specifically, the image of the sample 102) that is impinged on theimaging lens 106 f through the objective lens 106 a and the dichroicmirror 106 b. FIG. 1 depicts one example where luminescent imagescorresponding to two luminescence separated by the dichroic mirror 106 bare separately captured by the two CCD cameras 106 c. When oneluminescence is used, the luminescent image capturing unit 106 mayinclude the objective lens 106 a, one CCD camera 106 c, and the imaginglens 106 f.

Here, when the amount of the luminescence is measured according to colorusing two-color luminescence, the luminescent image capturing unit 106may include, as shown in FIG. 2, the objective lens 106 a, the CCDcamera 106 c, a split image unit 106 d, and the imaging lens 106 f. TheCCD camera 106 c may capture a luminescent image (split image) and abright-field image of the sample 102 that are projected on the chipsurface of the CCD camera 106 c through the split image unit 106 d andthe imaging lens 106 f. As with the dichroic mirror 106 b, the splitimage unit 106 d is used to separate the luminescence emitted from thesample 102 according to color and used when the amount of theluminescence according to color using two-color luminescence ismeasured.

Further, when the amount of the luminescence is measured according tocolor using plural-color luminescence (namely, when multicoloredluminescence is used), the luminescent image capturing unit 106 mayinclude, as shown in FIG. 3, the objective lens 106 a, the CCD camera106 c, a filter wheel 106 e, and the imaging lens 106 f. The CCD camera106 c may capture a luminescent image and a bright-field image of thesample 102 that are projected on the chip surface of the CCD camera 106c through the split image unit 106 d and the imaging lens 106 f. Thefilter wheel 106 e is used to replace the filter to separate theluminescence emitted from the sample 102 according to color and usedwhen the amount of the luminescence according to color usingplural-color luminescence is measured.

Referring to FIG. 1 again, the fluorescent image capturing unit 108 isspecifically an inverted fluorescence microscope and captures afluorescent image of the sample 102. As shown in the drawing, thefluorescent image capturing unit 108 includes an objective lens 108 a, adichroic mirror 108 b, a light source 108 c, a CCD camera 108 d, animaging lens 108 e, and a shutter 108 f. Specifically, objective lens108 a has a value not less than 0.01 found by (NumericalAperture/magnification)². The dichroic mirror 108 b transmits thefluorescence from the sample 102 and changes the direction of excitationlight so as to irradiate the sample 102 with the excitation lightemitted from the light source 108 c. The light source 108 c is providedto emit excitation light, and examples thereof include lamps such asxenon lamps and halogen lamps, laser, LED, and the like. The CCD camera108 d captures the fluorescent image and bright-field image of thesample 102 that are projected on the chip surface of the CCD camera 108d through the objective lens 108 a, the dichroic mirror 108 b, and theimaging lens 108 e. Further, the CCD camera 108 d is connected to theinformation communication terminal 110 to enable either wired orwireless communication. Here, when samples 102 are present in an area tobe captured, the CCD camera 108 d may capture the fluorescent image andbright-field image of samples 102 that are in the area to be captured.The imaging lens 108 e forms an image (specifically, the image of thesample 102) that is impinged on the imaging lens 108 e through theobjective lens 108 a and the dichroic mirror 108 b. The shutter 108 fswitches the excitation light emitted from the light source 108 c. Inother words, the shutter 108 f switches irradiating the sample 102 withthe excitation light by transmitting or intercepting the excitationlight emitted from the light source 108 c.

Here, the luminescent image capturing unit 106 and the fluorescent imagecapturing unit 108 may be specifically an inverted luminescencemicroscope and an inverted fluorescence microscope, respectively. Thestage 104 may be a rotation stage.

The predetermined site luminescence measuring apparatus 100 as shown inFIGS. 1 and 14 is configured such that the luminescent image capturingunit 106 and the fluorescent image capturing unit 108 are providedseparately. However, the predetermined site luminescence measuringapparatus 100 may be configured such that the fluorescent imagecapturing unit 108 only is provided as shown in FIG. 15. In other words,the predetermined site luminescence measuring apparatus 100 may beconfigured so as to perform both fluorescent observation and luminescentobservation by the fluorescent image capturing unit 108 only. When thefluorescence and luminescence observation are performed by using thepredetermined site luminescence measuring apparatus 100 that is shown inFIG. 15, the predetermined site luminescence measuring apparatus 100 ispreferably configured such that switching of the shutter 108 f isperformed automatically or manually in capturing a luminescent image (inperforming luminescence detection) and the dichroic mirror 108 b can bemoved to the position off an optical path (shown by the dotted line inFIG. 15) automatically or manually. This allows for reduction of noisein the luminescent image. In the predetermined site luminescencemeasuring apparatus 100 shown in FIG. 15, the objective lens 108 apreferably satisfies the condition “the value found by (NumericalAperture/magnification)² is 0.01 or more”.

Further, the predetermined site luminescence measuring apparatus 100shown in FIG. 16, may be configured to irradiate the sample 102 withexcitation light from above and perform the observation of fluorescenceand luminescence from below the sample 102. Here, among theconfiguration of the predetermined site luminescence measuring apparatus100 shown in FIG. 16, only the configuration which has not beendescribed so far will be described. A spectral filter for excitation 108g separates the excitation light emitted from the light source 108 cinto multiple excitation light with different wavelength regions. Anoptical fiber 108 h conducts each of the excitation light separated bythe spectral filter for excitation 108 g to the sample 102. A condenserlens 108 i is used to uniformly illuminate the sample 102 and collectseach of the excitation light conducted by the optical fiber 108 h. Afilter for luminescence and fluorescence spectra 108 j separates thefluorescence and luminescence emitted from the sample 102 depending onthe differences in the intensity or the wavelengths. In thepredetermined site luminescence measuring apparatus 100 shown in FIG.16, the objective lens 108 a preferably satisfies the condition “thevalue found by (Numerical Aperture/magnification)² is 0.01 or more”.

Referring to FIG. 1 again, information communication terminal 110 isspecifically a personal computer. As shown in FIG. 4, the informationcommunication terminal 110 includes, when classified roughly, acontrolling unit 112, a clock generating unit 114 that generates a clockfor the system, a storage unit 116, a communication interface unit 118,an input/output interface unit 120, an input unit 122, and an outputunit 124. These respective units are connected through a bus.

The storage unit 116 is storage means, and usable examples thereofinclude memory devices such as RAM and ROM; fixed disk devices such ashard disks; flexible disks; optical disks; and the like. The storageunit 116 stores data obtained by processing of each unit in thecontrolling unit 112.

The communication interface unit 118 mediates communications in theinformation communication terminal 110, the CCD camera 106 c, and theCCD camera 108 d. That is, the communication interface unit 118 has afunction of communicating data with other terminals via wired orwireless communication lines.

The input/output interface unit 120 is connected to the input unit 122or the output unit 124. Here, in addition to a monitor (includinghousehold-use televisions), a speaker or a printer can be used as theoutput unit 124 (hereinafter, the output unit 124 is sometimes describedas a monitor). Further, a monitor which cooperates with a mouse torealize a pointing device function can be used as the input unit 122 inaddition to a microphone, a keyboard, and a mouse.

The controlling unit 112 has an internal memory to store a controlprogram such as OS (Operating System), a program in which various kindsof procedures are defined, and required data, and performs variousprocessing based on these programs. The controlling unit 112 includes,when classified roughly, a fluorescent image capture instructing unit112 a, a fluorescent image acquiring unit 112 b, a the determining unit112 c, a luminescent image capture instructing unit 112 d, a luminescentimage acquiring unit 112 e, a selecting unit 112 f, a luminescencemeasuring unit 112 g, and a related substance quantifying unit 112 h.

The fluorescent image capture instructing unit 112 a instructs the CCDcamera 108 d to capture a fluorescent image and a bright-field imagethrough the communication interface unit 118. The fluorescent imageacquiring unit 112 b obtains a fluorescent image and a bright-fieldimage captured by the CCD camera 108 d through the communicationinterface unit 118.

The determining unit 112 c determines whether a fusion gene isintroduced into the sample 102 and also determines whether thephotoprotein is localized at the predetermined site based on thefluorescent image and bright-field image obtained by the fluorescentimage acquiring unit 112 b. Here, when samples 102 are found in thefluorescent image and bright-field image obtained by the fluorescentimage acquiring unit 112 b, the determining unit 112 c, based on thefluorescent image and bright-field image, determines whether a fusiongene is introduced into the sample 102 for each sample 102 and alsodetermines whether the photoprotein is localized at the predeterminedsite for each sample 102.

The luminescent image capture instructing unit 112 d instructs the CCDcamera 106 c to capture a luminescent image and a bright-field imagethrough the communication interface unit 118. The luminescent imageacquiring unit 112 e obtains the luminescent image and bright-fieldimage captured by the CCD camera 106 c through the communicationinterface unit 118.

The selecting unit 112 f superimposes the fluorescent image andbright-field image obtained by the fluorescent image acquiring unit 112b as well as the luminescent image and bright-field image obtained bythe luminescent image acquiring unit 112 e and then selects the sample102 for measurement from the samples 102 whose results show thelocalization determined by the determining unit 112 c.

The luminescence measuring unit 112 g measures the luminescence from thesamples 102 whose results show the localization determined by thedetermining unit 112 c or the sample 102 selected by the selecting unit112 f based on the luminescent image. The related substance quantifyingunit 112 h quantifies the amount of a substance related directly orindirectly to changes in the amount of luminescence based on the amountof luminescence measured by the luminescence measuring unit 112 g. Forexample, when the photoprotein is luciferase, the related substancequantifying unit 112 h quantifies the amount of ATP, the substancerelated directly or indirectly to changes in the luminescence amount ofthe luciferase. Namely, the related substance quantifying unit 112 h canbe used as ATP quantifying means that quantifies ATP based on the amountof luminescence measured by the luminescence measuring unit 112 g.

In the above configuration, one example of the processing performed bythe predetermined site luminescence measuring apparatus 100 will bedescribed with reference to FIG. 5. Hereinafter, description will begiven to one example of the processing when the same fusion gene isintroduced into samples 102 and then the luminescence in thepredetermined site in a particular sample among the samples 102 ismeasured sequentially.

First, the information communication terminal 110 instructs the CCDcamera 108 d to capture a fluorescent image and a bright-field imagethrough the communication interface unit 118 in the processing of thefluorescent image capturing instruction unit 112 a (step SA-1). Next,the CCD camera 108 d captures the fluorescent image and bright-fieldimage of the samples 102 that are in the area to be captured (step SA-2:see FIG. 6); and transmitting them to the information communicationterminal 110 (step SA-3). In this regard, the sample 102 is irradiatedwith excitation light only when capturing a fluorescent image. Next, theinformation communication terminal 110 obtains the fluorescent image andbright-field image captured by the CCD camera 108 d through thecommunication interface unit 118 in processing of the fluorescent imageacquiring unit 112 b, and stores them in a predetermined storage area ofthe storage unit 116 (step SA-4).

Next, the information communication terminal 110 determines whether afusion gene is introduced into each sample 102 by comparing thefluorescent image with the bright-field image in processing of thedetermining unit 112 c, and determines whether the photoprotein islocalized at the predetermined site for each sample 102 in the sample102 into which the fusion gene is determined to be introduced (stepSA-5). This makes it possible to identify, as shown in FIG. 6, a cell(cell 1) in which the gene is introduced and the photoprotein islocalized at the predetermined site from among, for example, the samples102 (cells 1 to 5).

Next, when the sample 102 in which the gene is introduced and thephotoprotein is localized at the predetermined site is present (stepSA-6: Yes), the information communication terminal 110 instructs the CCDcamera 106 c to capture a luminescent image and a bright-field imagethrough the communication interface unit 118 in the processing of theluminescent image capture instructing unit 112 d (step SA-7). Next, theCCD camera 106 c captures the luminescent image and bright-field imageof samples 102 that are in the area to be captured (step SA-8: see FIG.7), and transmits them to the information communication terminal 110(step SA-9). The luminescent image shown in FIG. 7 indicates one examplewhen luminescence of the cell 2 is the strongest.

Next, the information communication terminal 110 obtains the luminescentimage and bright-field image captured by the CCD camera 106 c throughthe communication interface unit 118 in processing of the luminescentimage acquiring unit 112 e, and in processing of the controlling unit112, obtains a time clock (corresponding to T1 in FIG. 8 which will bedescribed later) from the clock generating unit 114, and stores theluminescent image, the bright field, and the time clock in apredetermined storage area of the storage unit 116 correspondingly tothe fluorescent image and bright-field image which have already beenstored, (step SA-10).

Next, the information communication terminal 110 superimposes thebright-field image, fluorescent image, and luminescent image, andselects (identifies) a sample for measurement from the samples where thelocalization determined by the determining unit 112 c in processing ofthe selecting unit 112 f (step SA-11). In the example shown in FIG. 6,the cell into which the gene is introduced and a photoprotein islocalized at the predetermined site is the cell 1 only. Therefore, thecell 1 is automatically identified in step SA-11 as shown in FIG. 8.

Next, the information communication terminal 110 measures, in processingof the luminescence measuring unit 112 g, the luminescence correspondingto the selected sample 102 (luminescence intensity) based on aluminescent image, stores the identification information that identifiesthe selected sample 102 (for example, the cell 1 in FIG. 8) and theamount of luminescence correspondingly to the fluorescent image,luminescent image, bright-field image, and time clock which have alreadybeen stored, in a predetermined storage area of the storage unit 116(step SA-12).

As shown in FIG. 9, the information communication terminal 110sequentially (for example, per time clocks T₁ to T₄ shown in FIGS. 8 and9) obtains changes of the luminescence amount in the predetermined siteof the selected sample 102 (for example, the cell 1 shown in FIGS. 6, 7,and 8) by repeatedly performing the above-mentioned steps SA-1 to SA-12,for example, at the time interval that is set up in advancepredetermined times in processing of the controlling unit 112 (SA-13).

As described in detail above, according to the predetermined siteluminescence measuring apparatus 100, a fusion gene to be introducedinto the sample 102 is obtained by fusing the targeting base sequence,the luminescence-related gene, and a fluorescence-related gene whichexpresses a fluorescence protein. A fluorescent image of the sample 102into which the fusion gene is introduced is captured, it is determinedwhether a photoprotein is localized at the predetermined site or notbased on the captured fluorescent image, and the luminescence from thesample 102 is measured when the localization is determined as thedetermined result. This allows for determining whether, when theluminescence from the predetermined site in live samples 102 ismeasured, the photoprotein is localized at the predetermined site in thesamples 102 themselves. Localization of a photoprotein in live samplesinto which a fusion gene is introduced is determined and theluminescence from the sample is measured, so that the amount ofluminescence from the sample corresponds to the amount of luminescencefrom the predetermined site clearly. Therefore, it is possible to ensurereliability in which the measured luminescence amount is obtained fromthe predetermined site. For example, when the sample 102 is a cell,exact statistical analysis can be carried out without counting the cellinto which no luminescence component is incorporated. Further, thepredetermined site luminescence measuring apparatus 100 can bepreferably used in, for example, examinations of various types ofreactions (for example, drug stimulation, light exposure, etc.) ortreatments.

According to the predetermined site luminescence measuring apparatus100, when multiple live samples 102 into which the fusion gene isintroduced are present in the area to be captured, a fluorescent imageof the samples 102 is captured, it is determined whether or not aphotoprotein is localized at the predetermined site for each sample 102based on the fluorescent image, and a luminescent image of the samples102 is captured. The sample 102 for measurement is selected from thesamples 102 whose results show the localization determined bysuperimposing the captured fluorescent image and the capturedluminescent image. Then, the luminescence from the selected sample 102is measured. Thus, individual samples 102 are distinguished from oneanother, and the luminescence at the predetermined site can be measuredin a single sample 102. Alternatively, it is possible to determine thelocalization of a photoprotein in the sample 102 themselves for analysisand the luminescence intensity emitted from the sample 102 by obtainingthe fluorescence and luminescence as images. Thus, analysis can beperformed without the influence of different physiological states ofindividual cells due to the efficiency of gene transduction or the cellcycle. Here, in the predetermined site luminescence measuring apparatus100 according to the embodiment as shown in FIG. 5, for example,determines whether or not the photoprotein is localized at thepredetermined site after capturing a fluorescent image, and captures aluminescent image when the localization is determined. However, thecapture of a luminescent image may be performed together with thecapture of a fluorescent image. In other words, the predetermined siteluminescence measuring apparatus 100 may determine the localizationafter capturing the fluorescent image and luminescent image.Specifically, the predetermined site luminescence measuring apparatus100 may, when multiple live samples 102 into which the fusion gene isintroduced are present in the area to be captured, capture thefluorescent image and luminescent image of the samples 102, determineswhether or not the photoprotein is localized at the predetermined sitefor each sample 102 based on the fluorescent image, selects the sample102 for measurement from the samples 102 where the localization isdetermined by superimposing the captured fluorescent image and thecaptured luminescent image, and measures the luminescence from theselected sample 102.

Further, according to the predetermined site luminescence measuringapparatus 100, the amount of luminescence from the predetermined site insamples 102 is obtained sequentially by repeatedly performing thecapture of a fluorescent image, the determination of the localization,the capture of a luminescent image, the selection of the sample 102 formeasurement, and the measurement of the luminescence. Thus, it ispossible to measure sequentially changes of the amount of luminescencefrom the predetermined site, for example, in particular samples 102.

Here, in the predetermined site luminescence measuring apparatus 100,multiple fusion genes to be introduced into the sample are present. Thegenes may be produced in advance so that each combination of a targetedsite to which a photoprotein is directed by the targeting base sequence,a luminescent color of luminescence emitted from the photoprotein, and afluorescent color of fluorescence emitted from the fluorescence proteinis different. In this case, the predetermined site luminescencemeasuring apparatus 100 may separate the luminescence from the sample102 in accordance with luminescent color, determine whether or not aphotoprotein is localized at the predetermined site for each fluorescentcolor, specify the luminescence from the site where the localization ofphotoprotein is determined among multiple luminescence separated whenthe localization is determined as a result, and measure the specifiedluminescence. This makes it possible, for example, to measure theluminescence from multiple sites in one sample 102 at the same time, orto measure the luminescence from multiple sites in the sample 102 foreach sample 102 at the same time.

Specifically, when the sample 102 is a cell, two fusion genes to beintroduced into cell may be prepared. One of the fusion genes may beprepared in the combination of a targeted site to which green luciferaseis directed by a mitochondrial targeting signal, a luminescent color(green) of luminescence emitted from the green luciferase, and afluorescent color (green) of fluorescence emitted from GFP, and theother one may be produced in the combination of a luminescent color(red) of luminescence emitted from red luciferase which is expressed incytoplasm, and a fluorescent color (cyanogen) of fluorescence emittedfrom CFP. In this case, the predetermined site luminescence measuringapparatus 100 may separate the luminescence from the cell in accordancewith luminescent color (green, red); determine whether or not greenluciferase is localized in mitochondria by the fluorescent color (green)emitted from GFP based on the captured fluorescent image as well asdetermine whether red luciferase is localized in cytoplasm by thefluorescent color (cyanogen) emitted from CFP; specify the luminescencefrom the site where the localization is determined among twoluminescence (green, red) separated when the localization is determinedas a result; and measure the specified luminescence. In other words, amitochondrial targeting signal as a targeting base sequence, greenluciferase as a photoprotein, and GFP as a fluorescence protein may beselected for an intracellular mitochondria. On the other hand, forcytoplasm in the cells, a targeting base sequence is not used and redluciferase as photoprotein and CFP as a fluorescence protein may beselected, and changes of the amount of luminescence in mitochondria andcytoplasm (further, the amount of ATP etc.) may measured individuallyand at the same time as changes of luminescence intensity.

Further, as for the predetermined site luminescence measuring apparatus100, the amount of the substance related directly or indirectly to theincreased or lessened luminescence may be quantified based on themeasured luminescence amount. Specifically, when the photoprotein isluciferase, for example, the amount of ATP that is a substance relateddirectly or indirectly to the increased or lessened luciferase may bequantified. This makes it possible to, for example, measure sequentiallychanges of the amount of a related substance (for example, ATP etc.) atthe predetermined site in particular samples 102.

As another embodiment, for example, a method may include producing cellscontaining the fluorescence protein and photoprotein in which theexpression amount and/or the localization site is changed for each cellcycle stage, and sequentially measuring the fluorescence andluminescence which are emitted from the cells, thereby to confirm thecell cycle by changes of the expression amount of a fluorescence proteinand/or changes of localization site, and sequentially measure changes ofthe amount of luminescence of cells.

When multiple nerve cells are used, a fusion gene to be introduced intonerve cells may be produced by fusing a luminescence-related gene whichexpresses a photoprotein, a targeting base sequence that directs aphotoprotein to another nerve cell, and a fluorescence-related genewhich expresses a fluorescence protein. A process in which aphotoprotein is transferred to another nerve cell from the nerve cellinto which the fusion gene is introduced is confirmed by the fluorescentcolor emitted from the nerve cell, so that changes of the amount ofluminescence in the nerve cell may be measured sequentially in thetransferring process.

(Additional Remark)

There is provided a method for measuring fluorescence and luminescence,including:

a fluorescence measuring step of measuring fluorescence intensityemitted from a sample into which a fusion gene is introduced, the fusiongene being obtained by fusing a fluorescence-related gene whichexpresses a fluorescence protein and a luminescence-related gene whichexpresses a photoprotein including;

a position specifying step of specifying a position of the sample basedon the fluorescence intensity measured by the fluorescence measuringstep;

a luminescence measuring step of measuring luminescence intensity ofluminescence emitted from the sample; and

a luminescence amount quantifying step of quantifying the luminescenceamount based on the luminescence intensity measured by the luminescencemeasuring step.

[II] Hereinbelow, embodiments of an expression amount measuring methodin the present invention will be specifically described on the basis ofthe drawings. However, the present invention is not limited by theseembodiments.

First, the configuration of an expression amount measuring apparatus1000, that is an apparatus to perform the present invention, will bedescribed with reference to FIGS. 20 to 22. FIG. 20 is a diagram of anexample of the entire configuration of the expression amount measuringapparatus 1000.

As shown in FIG. 20, the expression amount measuring apparatus 1000includes a cell 1020, a container 1030 accommodating the cell 1020(specifically, a petri dish, a slide glass, a microplate, a gelsupporting matrix, a particulate carrier, etc.), a stage 1040 on whichthe container 1030 is arranged, a luminescent image capturing unit 1060,a fluorescent image capturing unit 1080, and an informationcommunication terminal 1100. In the expression amount measuringapparatus 1000, as shown in the figure, an objective lens 1060 aincluded in the luminescent image capturing unit 1060 and an objectivelens 1080 a included in the fluorescent image capturing unit 1080 arearranged in vertically opposed positions across the cell 1020, thecontainer 1030, and the stage 1040. The arrangement of the luminescentimage capturing unit 1060 and the fluorescent image capturing unit 1080may be replaced.

The cell 1020 may be a living cell into which a cell cycle-related geneexpressed at the specific stage of the cell cycle is introduced inaddition to a luminescence-related gene which expresses a photoprotein(specifically, luciferase), a fluorescence-related gene which expressesa fluorescence protein (specifically, GFP), and a gene to be analyzed.Here, the term “luminescence” used herein is a concept includingbioluminescence and chemiluminescence.

The cell 1020 may be a living cell into which a fusion gene isintroduced, the fusion gene being obtained by fusing theluminescence-related gene and the fluorescence-related gene, the gene tobe analyzed, and the cell cycle-related gene. Specifically, the cell1020 may be a living cell into which a vector obtained by fusing theluminescence-related gene and the fluorescence-related gene with thegene to be analyzed and the cell cycle-related gene is introduced.Further, the number of the genes to be analyzed introduced incombination with a luminescence related gene or a fluorescence relatedgene into the cell 1020 may be plural. In other words, plural pairs of agene to be analyzed and a luminescence-related gene or afluorescence-related gene may be introduced into the cell 1020. Thisallows for identifying the stage of the cell cycle and measuring theamount of expression of multiple genes to be analyzed introduced intothe cell 1020.

When the stage of the cell cycle is identified by fluorescence and theamount of expression of the gene to be analyzed is measured byluminescence, the cell 1020 may be a living cell into which afluorescence-related gene and a cell cycle-related gene are introducedin association with each other, and a luminescence-related gene and agene to be analyzed are introduced in association with each other.Specifically, the cell 1020 may be a living cell into which a vectorobtained by fusing a fluorescence-related gene with a cell cycle-relatedgene (specifically, a fluorescence-related gene introducing vector) isintroduced and a vector obtained by fusing a luminescence-related genewith a gene to be analyzed (specifically, a luminescence-related geneintroducing vector) is introduced.

Alternatively, the vector into which a cell cycle-related gene promoteris incorporated may be introduced into the cell 1020. Specifically, aGFP sensor (manufactured by Amersham Bioscience) into which the CyclinB1 promoter known as a cell-cycle marker is incorporated may beintroduced into the cell 1020. The cell 1020 may be fluorescentlylabeled by introducing a HaloTag (registered trademark) vector(manufactured by Promega KK) therein and adding a HaloTag (registeredtrademark) ligand (manufactured by Promega KK) thereto. Alternatively, aluciferase vector into which the gene promoter for analysis isincorporated may be introduced into the cell 1020 to give expressionthereof. Further, the cell 1020 may be labeled with luciferase byintroducing a HaloTag (registered trademark) vector (manufactured byPromega KK) therein and adding a HaloTag (registered trademark) ligand(manufactured by Promega KK) thereto.

When the stage of the cell cycle is identified by fluorescence and theamount of expression of the gene to be analyzed is measured byluminescence, the cell 1020 may be a living cell into which aluminescence-related gene and a gene to be analyzed are introduced andwhich is stained with fluorescent substances at the predetermined sitethereof (specifically, nucleus, cell membrane, cytoplasm, etc.).Specifically, the cell 1020 may be a living cell into which a fusiongene obtained by fusing a luminescence-related gene with a gene to beanalyzed (specifically, a vector obtained by fusing aluminescence-related gene with a gene to be analyzed) is introduced andwhich is stained with fluorescent substances at the predetermined sitethereof (specifically, nucleus, cell membrane, cytoplasm, etc.). Here,nuclei of cells 1020 may be stained with a live cell nuclear stainingreagent “DRAQ5” (manufactured by Biostatus Limited). Further, cellmembranes of cells 1020 may be stained with “PKH LinkerKits”(manufactured by SIGMA) (where in this case, cells in which the stage ofthe cell cycle can be identified by the shape (specifically, PC12 etc.)are used).

When the stage of the cell cycle is identified by luminescence and theamount of expression of the gene to be analyzed is measured byfluorescence, the cell 1020 may be a living cell into which aluminescence-related gene and a cell cycle-related gene are introducedin association with each other, and a fluorescence-related gene and agene to be analyzed are introduced in association with each other.Specifically, the cell 1020 may be a living cell into which a vectorobtained by fusing a luminescence-related gene with a cell cycle-relatedgene (specifically, a luminescence-related gene containing vector) isintroduced and a vector obtained by fusing a fluorescence-related genewith a gene to be analyzed (specifically, a fluorescence-related genecontaining vector) is introduced.

Alternatively, the vector into which a cell cycle-related gene promoteris incorporated may be introduced into the cell 1020. Specifically, aluciferase vector into which the Cyclin B1 promoter is incorporated isproduced, which is then introduced into the cell 1020. Further, the cell1020 may be labeled with luciferase by introducing a HaloTag (registeredtrademark) vector (manufactured by Promega KK) therein and adding aHaloTag (registered trademark) ligand (manufactured by Promega KK)thereto.Alternatively, a fluorescent protein vector into which the gene promoterfor analysis is incorporated may be introduced into the cell 1020 togive expression thereof. The cell 1020 may be fluorescently labeled byintroducing a HaloTag (registered trademark) vector (manufactured byPromega KK) therein and adding a HaloTag (registered trademark) ligand(manufactured by Promega KK) thereto. Furthermore, a β-lactamase gene asa reporter gene may be introduced into the cell 1020.

Usable examples of the cell cycle-related gene include cycline(specifically, Cyclin A1, Cyclin A2, Cyclin B1, Cyclin B2, Cyclin B3,Cyclin C, Cyclin D1, Cyclin D2, Cyclin D3, Cyclin E1, Cyclin E2, CyclinF, Cyclin G1, Cyclin G2, Cyclin H, Cyclin I, Cyclin T1, Cyclin T2a,Cyclin T2b, etc.), cycline kinases (specifically, CDK2, CDK28, etc.),and the like. Usable examples of the gene to be analyzed include thecell cycle-related gene described above, circadian rhythm-regulatedgenes such as period genes, Kai genes, timeless genes, per genes, andclock genes, other genes whose relationship to the cell cycle isunknown, and the like.

Describing FIG. 20 again, the luminescent image capturing unit 1060 isspecifically an upright luminescence microscope and captures aluminescent image of the cell 1020. As shown in the drawing, theluminescent image capturing unit 1060 includes an objective lens 1060 a,a dichroic mirror 1060 b, and a CCD camera 1060 c. Specifically, theobjective lens 1060 a has a value not less than 0.01 found by (NumericalAperture/magnification)². The dichroic mirror 1060 b is used to separateluminescence emitted from the cell 1020 according to color and measureluminescence intensity according to color using two-color luminescence.The CCD camera 1060 c captures the luminescent image and bright-fieldimage of the cell 1020 that are projected on the chip surface of the CCDcamera 1060 c through the objective lens 1060 a. The CCD camera 1060 cis connected to the information communication terminal 1100 to enableeither wired or wireless communication. Here, when cells 1020 arepresent in an area to be captured, the CCD camera 1060 c may capture theluminescent image and bright-field image of the cells 1020 that are inthe area to be captured. FIG. 20 depicts one example where luminescentimages corresponding to two luminescence separated by the dichroicmirror 1060 b are separately captured by two CCD cameras 1060 c. Whenone luminescence is used, the luminescent image capturing unit 1060 mayinclude the objective lens 1060 a and one CCD camera 1060 c.

Here, when the luminescence intensity is measured according to colorusing two-color luminescence, the luminescent image capturing unit 1060may include, as shown in FIG. 21, the objective lens 1060 a, the CCDcamera 1060 c, and a split image unit 1060 d. The CCD camera 1060 c maycapture the luminescent image (split image) and bright-field image ofthe cell 1020 that are projected on the chip surface of the CCD camera1060 c through the split image unit 1060 d. As with the dichroic mirror1060 b, the split image unit 1060 d is used to separate the luminescenceemitted from the cell 1020 according to color and measure luminescenceintensity according to color using two-color luminescence.

Further, when the luminescence intensity is measured according to colorusing plural-color luminescence (namely, when multicolored luminescenceis used), the luminescent image capturing unit 1060 may include, asshown in FIG. 22, the objective lens 1060 a, the CCD camera 1060 c, anda filter wheel 1060 e. The CCD camera 1060 c may capture the fluorescentimage and bright-field image of the cell 1020 that are projected on thechip surface of the CCD camera 1060 c through the filter wheel 1060 e.The filter wheel 1060 e is used to replace the filter to separate theluminescence emitted from the cell 1020 according to color and measureluminescence intensity according to color using plural-colorluminescence.

Referring to FIG. 20 again, the fluorescent image capturing unit 1080 isspecifically an inverted fluorescence microscope and captures afluorescent image of the cell 1020. As shown in the drawing, thefluorescent image capturing unit 1080 includes the objective lens 1080a, a dichroic mirror 1080 b, a xenon lamp 1080 c, and a CCD camera 1080d. The CCD camera 1080 d captures the fluorescent image and bright-fieldimage of the cell 1020 that are projected on the chip surface of the CCDcamera 1080 d through the objective lens 1080 a. The CCD camera 1080 dis connected to the information communication terminal 1100 to enableeither wired or wireless communication. Here, when cells 1020 arepresent in an area to be captured, the CCD camera 1080 d may capture thefluorescent image and bright-field image of the cells 1020 that are inthe area to be captured. The dichroic mirror 1080 b transmits thefluorescence from the cell 1020 and changes the direction of excitationlight so as to irradiate the cell 1020 with the excitation light emittedfrom the xenon lamp 1080 c. The xenon lamp 1080 c emits excitationlight.

Here, the luminescent image capturing unit 1060 and the fluorescentimage capturing unit 1080 may be specifically an inverted luminescencemicroscope and an inverted fluorescence microscope, respectively. Thestage 1040 may be a rotation stage.

The information communication terminal 1100 is specifically a personalcomputer. As shown in FIG. 23, the information communication terminal1100 includes, when classified roughly, a controlling unit 1120, a clockgenerating unit 1140 that generates a clock for the system, a storageunit 1160, a communication interface unit 1180, an input/outputinterface unit 1200, an input unit 1220, and an output unit 1240. Theserespective units are connected through a bus.

The storage unit 1160 is storage means, and usable examples thereofinclude memory devices such as RAM and ROM; fixed disk devices such ashard disks; flexible disks; and optical disks. The storage unit 1160stores data obtained by processing of each unit in the controlling unit1120.

The communication interface unit 1180 mediates communications in theinformation communication terminal 1100, the CCD camera 1060 c, and theCCD camera 1080 d. That is, the communication interface unit 1180 has afunction of communicating data with other terminals via wired orwireless communication lines.

The input/output interface unit 1200 is connected to the input unit 1220or the output unit 1240. Here, in addition to a monitor (includinghousehold-use televisions), a speaker or a printer can be used as theoutput unit 1240 (hereinafter, the output unit 1240 is sometimesdescribed as a monitor). Further, a monitor which cooperates with amouse to realize a pointing device function can be used as the inputunit 1220 in addition to a microphone, a keyboard, and a mouse.

The controlling unit 1120 has an internal memory to store a controlprogram such as OS (Operating System), a program in which various kindsof procedures are defined, and required data, and performs variousprocessing based on these programs. The controlling unit 1120 includes,when classified roughly, a fluorescent image capture instructing unit1120 a, a luminescent image capture instructing unit 1120 b, afluorescent image acquiring unit 1120 c, a luminescent image acquiringunit 1120 d, a determining unit 1120 e, a fluorescence measuring unit1120 f, a luminescence measuring unit 1120 g, a stage identifying unit1120 h, a selecting unit 1120 i, and an expression measuring unit 1120j.

The fluorescent image capture instructing unit 1120 a instructs the CCDcamera 1080 d to capture a fluorescent image or a bright-field imagethrough the communication interface unit 1180. The luminescent imagecapture instructing unit 1120 b instructs the CCD camera 1060 c tocapture a luminescent image or a bright-field image through thecommunication interface unit 1180. The fluorescent image acquiring unit1120 c obtains the fluorescent image and bright-field image captured bythe CCD camera 1080 d through the communication interface unit 1180. Theluminescent image acquiring unit 1120 d obtains the luminescent imageand bright-field image captured by the CCD camera 1060 c through thecommunication interface unit 1180.

The determining unit 1120 e determines whether respective genes areintroduced or not into each cell 1020 based on the fluorescent imageand/or the luminescent image. The fluorescence measuring unit 1120 findividually measures fluorescence intensity emitted from each cell 1020based on the fluorescent image captured by the CCD camera 1080 d. Theluminescence measuring unit 1120 g individually measures luminescenceintensity of luminescence emitted from each cell 1020 based on theluminescent image captured by the CCD camera 1060 c.

The stage identifying unit 1120 h identifies the stage of the cell cyclefor each cell 1020 by determining whether a cell cycle-related gene isexpressed or not in each cell 1020 on the basis of the fluorescenceintensity measured by the fluorescence measuring unit 1120 f or theluminescence intensity measured by the luminescence measuring unit 1120g. When identifying a living cell 1020 into which a luminescence-relatedgene and a gene to be analyzed are introduced and which is stained witha fluorescent substance at the predetermined site (specifically,nucleus, cell membrane, cytoplasm, etc.), the stage of the cell cyclemay be identified by determining whether or not the shape of the cell1020 is changed based on the fluorescent image captured by the CCDcamera 1080 d. The selecting unit 1120 i selects the cells 1020 formeasurement from among the cells 1020 whose stages are identified by thestage identifying unit 1120 h.

The expression measuring unit 1120 j measures the amount of expressionof the gene to be analyzed based on the measured fluorescence intensityby the fluorescence measuring unit 1120 f when luminescence intensity isused in the stage identifying unit 1120 h in the selected cells 1020 bythe selecting unit 1120 i, and measures the amount of expression of thegene to be analyzed based on the measured luminescence intensity by theluminescence measuring unit 1120 g when fluorescence intensity orfluorescent image is used in the stage identifying unit 1120 h. In thisregard, the expression measuring unit 1120 j may measure the amount ofexpression of the gene to be analyzed in cells 1020 or the selectedcells 1020 by the selecting unit 1120 i based on the measuredfluorescence intensity by the fluorescence measuring unit 1120 f, andmay identify expression sites in cells 1020 of the gene to be analyzedbased on the captured fluorescent image by the CCD camera 1080 d.

In the above configuration, one example of the processing performed bythe expression amount measuring apparatus 1000 will be described withreference to FIG. 24. That is, a vector obtained by fusing aluminescence-related gene and a cell cycle-related gene and a vectorobtained by fusing a fluorescence-related gene and a gene to be analyzedare introduced into cells 1020. While the stage of the cell cycle in aspecific cell 1020 among the cells 1020 is identified by theluminescence intensity, the amount of expression of the gene to beanalyzed is measured by the fluorescence intensity sequentially, and theexpression site in the cell 1020 of the gene to be analyzed isidentified by a fluorescent image sequentially.

First, the information communication terminal 1100 instructs the CCDcamera 1080 d to capture a fluorescent image through the communicationinterface unit 1180 in processing of the fluorescent image capturinginstruction unit 1100 a, and instructs the CCD camera 1060 c to capturea luminescent image through the communication interface unit 1180 inprocessing of the luminescent image capture instructing unit 1120 b(step SB-1). Next, the CCD camera 1080 d captures a fluorescent image ofthe cells 1020 that are in the area to be captured (step SB-2), andtransmits it to the information communication terminal 1100 (step SB-3).On the other hand, the CCD camera 1060 c captures a luminescent image ofthe cells 1020 that are in the area to be captured (step SB-4), andtransmits it to the information communication terminal 1100 (step SB-5).The instruction to capture a fluorescent image and the instruction tocapture a luminescent image may be performed at different times ordifferent time intervals. For example, a luminescent image to be usedfor identifying the stage of the cell cycle may be captured everyseveral hours, and a fluorescent image to be used for measuring theamount of expression of the gene to be analyzed may be captured everyseveral minutes. Additionally, the cell 1020 is irradiated withexcitation light only when capturing a fluorescent image.

Next, the information communication terminal 1100 includes:

(a) obtaining a fluorescent image through the communication interfaceunit 1180 in processing of the fluorescent image acquiring unit 1120 c;

(b) obtaining a luminescent image through the communication interfaceunit 1180 in processing of the luminescent image acquiring unit 1120 d;

(c) obtaining a time clock from the clock generating unit 1140 inprocessing of the controlling unit 1120; and

(d) storing correspondingly the fluorescent image, luminescent image,and the time clock which are obtained and storing them in apredetermined storage area of the storage unit 1160 (step SB-6).

Next, the information communication terminal 1100 determines whether avector is introduced or not into each cell 1020 based on the fluorescentimage and/or the luminescent image in the processing of the determiningunit 1120 e (step SB-7). When at least one cell 1020 into which a vectoris introduced is present (step SB-8: Yes), the information communicationterminal 1100 measures fluorescence intensity of the fluorescenceemitted from each cell 1020 by processing of the fluorescence measuringunit 1120 f based on the fluorescent image, and measures luminescenceintensity of the luminescence emitted from each cell 1020 by processingof the luminescence measuring unit 1120 g based on the luminescent image(step SB-9).

Next, the information communication terminal 1100 identifies the stageof the cell cycle for each cell 1020 by determining whether the cellcycle-related gene is expressed or not in each cell 1020 based on theluminescence intensity in the processing of the stage identifying unit1120 h (step SB-10). In this regard, when a vector which is fused with afluorescence-related gene and a cell cycle-related gene as well as avector which is fused with a luminescence-related gene and a gene to beanalyzed are introduced into cells 1020, the stage of the cell cycle maybe identified for each cell 1020 by determining whether a cellcycle-related gene is expressed or not in each cell 1020. When a vectorwhich is fused with a luminescence-related gene and the gene to beanalyzed is introduced into cells 1020 and the predetermined site(specifically, nucleus, cell membrane, cytoplasm, etc.) are stained withfluorescent substances, the stage of the cell cycle may be identified bydetermining whether or not the shape of the cell 1020 is changed basedon the fluorescent image for each cell 1020.

Next, the information communication terminal 1100 selects the cell 1020for measurement from among the cells 1020 whose stages are identified atstep SA-10 in the processing of the selecting unit 1120 i (step SB-11).Then, the information communication terminal 1100 measures the amount ofexpression of the gene to be analyzed in the selected cells 1020 at stepSB-11 based on the measured fluorescence intensity, and identifiesexpression sites of the gene to be analyzed in the cells 1020 based onthe captured fluorescent image in the processing of the expressionmeasuring unit 1120 j (step SB-12). When the fluorescence intensity orthe fluorescent image is used in SB-10, the expression amount of thegene to be analyzed may be measured based on the luminescence intensityin step SB-12.

The information communication terminal 1100 repeatedly performs theabove-mentioned processing steps SB-1 to step SB-12 at the time intervalthat is set up in advance predetermined times in processing of thecontrolling unit 1120, and stopping the processing when the step isperformed for predetermined times (step SB-13: Yes).

Here, only the image capture and acquisition of a luminescent image anda fluorescent image are repeatedly performed, so that measurement ofluminescence intensity, measurement of fluorescence intensity,identification of the stage, selection of the cell 1020, and measurementof the expression amount may be performed at the time of analysis. Thatis, only the luminescent image and fluorescent image which are originaldata required for analysis are obtained collectively, and thenmeasurement of luminescence intensity, measurement of fluorescenceintensity, identification of the stage, selection of the cell 1020, andmeasurement of the expression amount may be performed at the time ofanalysis. Specifically, selection of the cell 1020 and measurement ofthe expression amount may be performed at the time of analysis afterobtaining of a luminescent image and a fluorescent image. Further,identification of the stage and selection of the cell 1020 may beperformed at the time of analysis after obtaining a luminescent imageand a fluorescent image. Furthermore, selection of the cell 1020 may beperformed at the time of analysis after obtaining a luminescent imageand a fluorescent image.

After obtaining a fluorescent image, the cell 1020 for measurement maybe selected and a luminescent image may be obtained.

As described in detail above, according to the expression amountmeasuring apparatus 1000, in living cells 1020 into which aluminescence-related gene, a fluorescence-related gene, and a gene to beanalyzed are introduced, the luminescence intensity of the luminescenceemitted from cells 1020 is measured, the fluorescence intensity of thefluorescence emitted from cells 1020 is measured, and the amount ofexpression of a gene to be analyzed is measured based on the measuredluminescence intensity or the measured fluorescence intensity. In thiscase, the cells are cells into which the cell cycle-related gene isintroduced in addition to the luminescence-related gene, thefluorescence-related gene, and the gene to be analyzed. The stage of thecell cycle is identified by determining whether a cell cycle-relatedgene is expressed or not based on the measured fluorescence intensitywhen luminescence intensity is used to measure the amount of expression,or based on the measured luminescence intensity when fluorescenceintensity is used to measure the amount of expression. Thus, when theamount of expression of the gene to be analyzed introduced into cells1020 is measured, the stage of the cell cycle can be identified in cells1020 without performing the synchronized culture method, resulting inreducing the procedural burden on experimenters. Further, that producesan effect in which the relationship between the gene to be analyzed andthe stage of the cell cycle can be evaluated. Specifically, withreference to the gene to be analyzed whose direct involvement in thecell cycle is unknown, change in expression which is caused byadministration of a medicine or temperature changes can be obtained inaddition to the stage of the cell cycle, which allows for verifying therelation between the gene to be analyzed and the cell cycle. Further,with reference to the gene to be analyzed considered to be directlyinvolved in the cell cycle, both the amount of expression of the gene tobe analyzed and the stage of the cell cycle can be obtained, therebyenabling to evaluate whether the gene to be analyzed is useful as acell-cycle marker. When living cells 1020 into which aluminescence-related gene that expresses a photoprotein and the gene tobe analyzed are introduced and stained with fluorescent substances atthe predetermined site (specifically, nucleus, cell membrane, cytoplasm,etc.), the expression amount measuring apparatus 1000 may measure theluminescence intensity of the luminescence emitted from the cell 1020and measure the amount of expression of the gene to be analyzed based onthe measured luminescence intensity and capture the fluorescent image ofthe cell 1020 and identify the stage of the cell cycle by determiningwhether or not the shape of the cell 1020 is changed based on thefluorescent image captured by the CCD camera 1080 d. In this regard,with exception of the method for confirming incorporation of aluminescence inducing protein gene, fluorochrome may be used in place ofa fluorescence fusion gene, while the number of times as for the imagecapture for a fluorochrome can be decreased compared to the case of theimage capture only for fluorescence in order to minimize the effect ofphototoxicity by excitation light. Further, the expression amountmeasuring apparatus 1000 can be preferably used in, for example,examinations of various types of reactions (for example, drugstimulation, light exposure, etc.) or treatments.

Here, cells at various stages have been handled as a group of data inperforming the reporter assay. The cell cycle includes multipleconsecutive reactions consisting of the growth of cells, the DNAduplication, the distribution of chromosomes, the cell division, and thelike. Therefore, it is just conceivable that the expression of variousgenes varies depending on each stage of the cell cycle. Consequently,use of the expression amount measuring apparatus 1000 provides thefollowing effect. When with reference to the gene to be analyzed whosedirect involvement in the cell cycle is unknown, change in expressionwhich is caused by a certain stimulation such as administration of amedicine, temperature changes, or the like is detected, and moredetailed analysis results can be obtained by matching to data on thestage of the cell cycle. When the expression amount measuring apparatus1000 is used, the stage of the cell cycle as for the gene whose directinvolvement in the cell cycle is suggested can be discriminated for eachcell. Thus, operation such as the synchronized culture that hasconventionally been performed is not needed and only the cell whosestage is desired to analyze can be selected and observed.

According to the expression amount measuring apparatus 1000, when cells1020 are present in an area to be captured, a fluorescent image of thecells 1020 is captured and a luminescent image of cells 1020 iscaptured. Luminescence intensity of the luminescence emitted from eachcell 1020 is respectively measured based on the captured luminescentimage, and fluorescence intensity of the fluorescence emitted from eachcell 1020 is respectively measured based on the captured fluorescentimage. Then, the amount of expression of the gene to be analyzed foreach cell 1020 is measured based on the measured luminescence intensityor the measured fluorescence intensity. The stage of the cell cycle isidentified for each cell 1020 by determining whether a cellcycle-related gene is expressed or not in each cell 1020 based on themeasured fluorescence intensity when luminescence intensity is used tomeasure the amount of expression, or based on the measured luminescenceintensity when fluorescence intensity is used to measure the amount ofexpression. This allows for measuring the amount of expression of thegene to be analyzed, in each of the cells 1020 and identifying the stageof the cell cycle for each cell 1020. Further, this produces an effectin which the relationship between the gene to be analyzed and the stageof the cell cycle can be evaluated for each cell 1020. Living cells 1020are identified in which a luminescence-related gene that expresses aphotoprotein and the gene to be analyzed are introduced and are stainedwith fluorescent substances at the predetermined site (specifically,nucleus, cell membrane, cytoplasm, etc.). In this case, the expressionamount measuring apparatus 1000 captures a luminescent image of thecells 1020 in the area, captures a fluorescent image of the cells 1020,measures luminescence intensity of the luminescence emitted from eachcell 1020, and measures the expression amount of the gene to be analyzedbased on the measured luminescence intensity, so as to identify thestage of the cell cycle for each cell 1020 by determining whether theshape of the cell 1020 is changed or not for each cell 1020 based on thefluorescent image captured by the CCD camera 1080 d. Alternatively,comparative evaluation of cells with the same conditions may beperformed by comparing for each cell cycle stage.

According to the expression amount measuring apparatus 1000, the cell1020 for measurement is selected from among cells 1020 whose stages areidentified, and the amount of expression of the gene to be analyzedintroduced into the selected cell 1020 is measured based on the measuredluminescence intensity or the measured fluorescence intensity. Thus,individual cells 1020 are distinguished from one another, and the amountof expression of the gene to be analyzed is measured in a single cell1020 and the stage of the cell cycle can be identified.

According to the expression amount measuring apparatus 1000, the amountof expression of the gene to be analyzed is measured sequentially byrepeatedly performing the capture of a luminescent image, the capture ofa fluorescent image, the measurement of luminescence intensity, themeasurement of fluorescence intensity, the identification of the stage,the selection of cells 1020, and the measurement of the amount ofexpression while the stage of the cell cycle is identified in theselected cells 1020. Thus, change in expression of the gene to beanalyzed can be measured sequentially in a single cell 1020 while thestage of the cell cycle is identified. When a luminescence-related genewhich expresses a photoprotein and a gene to be analyzed are introducedand living cells 1020 which are stained with fluorescent substances atthe predetermined site (specifically, nucleus, cell membrane, cytoplasm,etc.) are used, the expression amount measuring apparatus 1000 maymeasure the amount of expression of the gene to be analyzed sequentiallyby repeatedly performing the capture of a luminescent image, the captureof a fluorescent image, the measurement of luminescence intensity, theidentification of the stage, the selection of cells 1020, and themeasurement of the amount of expression while the stage of the cellcycle is identified in the selected cells 1020. Alternatively, a movingimage (or frame advance) in which the cell cycle is matched or one imagemay be displayed by viewing an image on the time-lapse image in whichdifferent cells in the same visual field are captured at the timedepending on each cell cycle or one image at the same time.

According to the expression amount measuring apparatus 1000, inmeasurement of the amount of expression, the amount of expression of thegene to be analyzed is measured in the selected cells 1020 based on themeasured fluorescence intensity and expression sites in cells 1020 ofthe gene to be analyzed are identified based on the captured fluorescentimage. This allows for not only the evaluation of the relationshipbetween the gene to be analyzed and the stage of the cell cycle, butalso the identification of the expression site in the cell 1020 of thegene to be analyzed.

Further, the use of expression amount measuring apparatus 1000 allowsfor evaluation of, for example, anticancer drug and its lead compound.Particularly, it can monitor whether an anticancer drug has a harmfuleffect on the efficiency of cell division or whether its lead compoundaffects the transcriptional activity of genes to be analyzed at the sametime. Furthermore, the use of the expression amount measuring apparatus1000 allows for examination of, for example, the relationship betweenthe cell cycle and morphology of cells. Especially, it is known that thecellular morphology as for PC12 cell varies depending on the stage ofthe cell cycle and differentiation stage. Detailed stage identificationby cell morphology can be performed in other neuroid cells and the cellmorphology itself can be used as a phase marker of the cell cycle ordifferentiation. Further, when the expression amount measuring apparatus1000 is used, for example, the expression period of the gene which canbe involved in the cell cycle and their localization are identified bydetecting the fluorescence while the cell cycle is monitored bydetecting the luminescence. This allowed for evaluating whether there isa relationship between the gene to be analyzed and the cell cycle, andthe usefulness of the gene to be analyzed as cell-cycle markers.

(III) Hereinbelow, exemplary embodiments of the microscope unit andmicroscope apparatus as the measuring apparatus according to the presentinvention will be described in detail with reference to the accompanyingdrawings. However, the present invention is not limited by theseembodiments. In addition, it should be noted that the same numeralreferences are applied to the same parts in the description of thedrawings.

First Embodiment

First, a microscope apparatus according to a first embodiment of thepresent invention will be described. FIG. 25 is a schematic diagram ofthe configuration of the microscope apparatus according to the firstembodiment of the invention. As shown in FIG. 25, a microscope apparatus100 a according to the first embodiment includes a fluorescencemicroscope unit 101 that performs the observation of fluorescence, aweak luminescence microscope unit 102 a that observes weak luminescence,a holding unit 7 as holding means which holds a specimen S in which aluminescent label and a fluorescent label are given, a monitor 9 thatdisplays such as a specimen image of the specimen S captured byrespective microscope units 101 and 102 a, and a control device PC1 thatcontrols all processing and movement of the microscope apparatus 100 a.The fluorescence microscope unit 101 and the weak luminescencemicroscope unit 102 a are arranged adjacent each other.

The fluorescence microscope unit 101 includes: a fluorescence imagingoptical system of high magnification that has an objective lens 1 as afluorescence objective lens and an imaging lens 2 as a fluorescenceimaging lens: an imaging device 3 as fluorescence imaging means thatcaptures a fluorescent specimen image which is the specimen image of thespecimen S formed by the fluorescence imaging optical system; anexcitation light source 4 that emits excitation light that excites thespecimen S; a lens 5 that concentrates the excitation light from theexcitation light source 4, and a fluorescence cube 6 as a fluorescenceunit.

The objective lens 1 has a large numerical aperture on the side of thespecimen, and converts the fluorescence emitted from each point of theluminescent label given to the specimen S into a substantially parallelpencil of rays. The imaging lens 2 concentrates the fluorescenceconverted into a substantially parallel pencil of rays by the objectivelens 1 and forms a fluorescent specimen image that is the specimen imageof the specimen S. The fluorescence imaging optical system forms afluorescent specimen image at high magnification of 40 times or more.The imaging device 3 has a solid state image sensor such as CCD andCMOS, and captures a fluorescent specimen image that is formed on theimaging surface of the solid state image sensor and then produces imagedata to output it to control device PC1.

The fluorescence cube 6 integrally includes an excitation filter 6 a asan excitation light transmitting filter that selectively transmitsexcitation light for exciting the specimen S, an absorption filter 6 bas a fluorescence transmitting filter that selectively transmits thefluorescence emitted from the specimen S excited by the excitationlight, and a dichroic mirror 6 c that reflects the excitation light andtransmits fluorescence. The excitation filter 6 a is a band pass filterthat extracts the excitation light of a predetermined wavelength bandfrom the lights of various wavelengths emitted from the excitation lightsource 4. The absorption filter 6 b is a long wave pass filter with apredetermined cutoff wavelength. Here, the absorption filter 6 b may bea band pass filter that extracts the fluorescence of a predeterminedwave range. The band pass filter is effective when the wavelengths ofthe weak luminescence and fluorescence emitted from the specimen S areclose.

The excitation light source 4 is realized by a mercury lamp, a xenonlamp, a laser, and the like. As excitation light irradiating means, theexcitation light source 4 and the lens 5 reflect the excitation lightemitted from the excitation light source 4 through the excitation filter6 a by the dichroic mirror 6 c and irradiate the specimen S with it. Inthis regard, the excitation light source 4 lights up and out inaccordance with instructions from the control device PC1.

The weak luminescence microscope unit 102 a includes a weak luminescenceimaging optical system of low magnification that has an objective lens11 as a weak luminescence objective lens and an imaging lens 12 as aweak luminescence imaging lens, and an imaging device 13 as weakluminescence capturing means that captures a weak luminescent specimenimage which is the specimen image of the specimen S formed by the weakluminescence imaging optical system.

The objective lens 11 has a large numerical aperture on the side of thespecimen, and converts weak luminescence that is self-emitted from eachpoint of the luminescent label that is given to the specimen S into asubstantially parallel pencil of rays. The imaging lens 12 concentratesthe weak luminescence converted into a substantially parallel pencil ofrays by the objective lens 11 and forms a weak luminescent specimenimage that is the specimen image of the specimen S. The weakluminescence imaging optical system forms the weak luminescent specimenimage at an imaging magnification lower than that of the fluorescenceimaging optical system. Here, it is desirable that the weak luminescenceimaging optical system satisfies (NAo/β)²≧0.01 when the numericalaperture (NA) on the side of the specimen is defined as NAo and theimaging magnification is defined as β.

The imaging device 13 has a solid state image sensor, such as CCD andCMOS, and captures the weak luminescent specimen image that is formed onthe imaging surface of the solid state image sensor and then producesimage data to outputs it to the control device PC1. In this regard, thesolid state image sensor included in the imaging device 13 is ahighly-sensitive monochrome CCD and it is preferable to use a cooled CCD(at about 0° C.).

The holding unit 7 has a holding member 7 a such as a prepared slide, aslide glass, a microplate, a gel supporting matrix, a particulatecarrier, and an incubator on which the specimen S is directly placed,and a movable stage 7 b that two-dimensionally moves the specimen Stogether with the holding member 7 a. The movable stage 7 b is driven bya stage driving unit 8 in accordance with instructions from the controldevice PC1.

The control device PC1 is realized by a processor, such as a computerwith CPU, and electrically connects the imaging devices 3 and 13, theexcitation light source 4, the stage driving unit 8, and the monitor 9,thereby to control the movement of the respective structural parts.Particularly, as image capture switch controlling means, the controldevice PC1 controls the image capture switching processing that switchesbetween the capture of a weak luminescent specimen image by the weakluminescence microscope unit 102 a and the capture of a fluorescentspecimen image by the fluorescence microscope unit 101 on the basis ofthe image characteristic of the weak luminescent specimen image capturedby the imaging device 13.

Here, the image capture switching processing controlled by the controldevice PC1 will be described. FIG. 26 is a flow chart of the procedurefor image capture switching processing. As shown in FIG. 26, the controldevice PC1 captures the weak luminescent specimen image of the specimenS that is moved to a visual field of the weak luminescence imagingoptical system by the movable stage 7 b (step S101). On the basis of thecaptured result, the control device PC1 determines whether or not thereis a region where the image intensity as the image characteristic of aweak luminescent specimen image is larger than a preset threshold in aweak luminescent specimen image (step S103). When it is determined thatthere is no region where the image intensity is larger than thethreshold (step S103: No), the control device PC1 repeatedly performsthe processing from step S101.

On the other hand, when it is determined that there is a region wherethe image intensity is larger than the threshold (step S103: Yes), thecontrol device PC1 records the weak luminescent specimen image capturedby step S101 (step S105); and moves the specimen S to the visual fieldof the fluorescence imaging optical system by the movable stage 7 b(step S107). The control device PC1 causes the imaging device 3 tocapture the fluorescent specimen image corresponding to the region wherethe image intensity of the weak luminescent specimen image is largerthan the threshold, and record it (step S109); and then the imagecapture switching processing is ended. In this regard, it is preferablethat when daily observation of the specimen S is performed, the controldevice PC1 may make a control to move the specimen S to the visual fieldof the weak luminescence imaging optical system again by the movablestage 7 b after step S109, and repeat the processing from step S101.Further, the capture in step S109 may be either time-lapse capture orone image. Alternatively, a moving image (or frame advance) in which thecell cycle is matched or one image may be displayed by viewing an imageon the time-lapse image in which different cells in the same visualfield are captured at the time depending on each cell cycle or one imageat the same time.

In steps S105 and S109, the control device PC1 stores the captured weakluminescent specimen image and fluorescent specimen image in a storageunit such as RAM that is included therein. In steps S101 and S109, thecontrol device PC1 may successively display the captured weakluminescent specimen image and fluorescent specimen image on the monitor9. Further, it is preferable that the control device PC1 turns off theexcitation light source 4 between steps S101 to S105, that is, while theweak luminescence of the specimen S is observed by the weak luminescencemicroscope unit 102 a, and controls to turn on the excitation lightsource 4 when fluorescence of the specimen S is observed by step S109.Alternatively, a shading device such as a shutter is provided on theoptical path from the excitation light source 4 to the fluorescence unit6, and the control device PC1 may be configured to control theirradiation of excitation light by opening and closing the shadingdevice instead of switching to turn on/off the excitation light source 4as non-irradiating means.

In this regard, the control device PC1 is configured to determine theswitch to fluorescent observation on the basis of the image intensity ofpartial region in a weak luminescent specimen image in step S103. It maybe configured to determine the switch on the basis of the imageintensity of the whole weak luminescent specimen image. The controldevice PC1 may obtain such image intensity, for example, as thecumulative image intensity from a predetermined time point up to thecurrent time point or as the instantaneous image intensity at thecurrent time. In this regard, when entire image intensity of the weakluminescent specimen image is obtained, a light-sensitive element suchas a photomultiplier may be used in place of the imaging device 13.

As described above, according to the microscope apparatus in the firstembodiment, the microscope apparatus includes the fluorescencemicroscope unit 101 for fluorescent observation and the weakluminescence microscope unit 102 a for weak luminescent observation,which are adjacently arranged, and the movable stage 7 b that moves thespecimen S to each of the visual fields of the fluorescence imagingoptical system and the weak luminescence imaging optical system. Withthis configuration, it is possible to switch the fluorescent observationand the weak luminescent observation properly and to switch from theobservation of weak luminescence to the observation of fluorescenceimmediately depending on the image intensity as the image characteristicof the weak luminescent specimen image.

While weak luminescence imaging optical system has been described as aninfinity-corrected optical system that forms a specimen image by theobjective lens 11 and the imaging lens 12, it may be configured as afinite-corrected optical system that forms a specimen image by only theobjective lens.

The observation of weak luminescence is switched to the observation offluorescence on the basis of the image characteristics, such as theimage intensity of the weak luminescent specimen image in the imagecapture switching processing mentioned above. The observation of weakfluorescence may be switched to the observation of luminescence on thebasis of the image characteristics, such as image intensity of thefluorescent specimen image when the intensity of excitation light withwhich the specimen S is irradiated or the intensity of fluorescencewhich is emitted from the specimen S is weak in the observation offluorescence and the damage to the specimen S caused by excitation lightand fluorescence is relatively little.

Second Embodiment

Next, a second embodiment of the present invention will be described. Inthe first embodiment mentioned above, the specimen S is moved to each ofthe visual fields of the fluorescence imaging optical system and theweak luminescence imaging optical system by the movable stage 7 b. Onthe other hand, in the second embodiment, the specimen S is arranged ineach visual field by moving the fluorescence imaging optical system andthe weak luminescence imaging optical system.

FIG. 27 is a schematic diagram of the configuration of a microscopeapparatus according to the second embodiment of the invention. As shownin FIG. 27, a microscope apparatus 200 in the second embodiment has afluorescence microscope unit 201 and a the weak luminescence microscopeunit 202 as with the microscope apparatus 100 a, and further has arotary drive unit 14, a fixed shaft 15 a, and a fixed shaft 15 b asoptical system moving means in an intermediate position between themicroscope units 201 and 202. Furthermore, the microscope apparatus 200has a holding unit 17 having a movable stage 17 b that has a smallerrange of movement in place of the holding unit 7 included in themicroscope apparatus 100 a, and has a control device PC2 instead of thecontrol device PC1. Other configurations are the same as those of thefirst embodiment, and the same numeral references are applied to thesame structural parts.

The fluorescence microscope unit 201 includes a casing 21 thatintegrally holds each of the same structural parts as the fluorescencemicroscope units 101. The weak luminescence microscope unit 202 includesa casing 22 that integrally holds each of the same structural parts asthe weak luminescence microscope unit 102 a.

The rotary drive unit 14 includes an axis of rotation that passesthrough the midpoint of a line segment connecting substantially centralpoints of the visual fields of a fluorescence imaging optical systemincluded in the fluorescence microscope unit 201 and a weak luminescenceimaging optical system included in the weak luminescence microscope unit202, the axis of rotation being substantially parallel to the opticalaxis of each optical system. The rotary drive unit 14 rotates and movesthe fluorescence microscope unit 201 and the weak luminescencemicroscope unit 202 held by the multiple fixed shafts 15 a and 15 baround the axis of rotation. Here, the fixed shafts 15 a and 15 b holdthe casings 21 and 22, respectively.

The movable stage 17 b moves the specimen S in an area approximatelyequal to the visual field of the weak luminescence imaging opticalsystem. Further, the movable stage 17 b is driven by a stage drivingunit 18 in accordance with instructions from the control device PC2.

The control device PC2 controls the movement of the imaging devices 3and 13, the excitation light source 4, and the stage driving unit 18 inthe same manner as the control device PC1, and controls the movement ofthe rotary drive unit 14. The control device PC2 controls the rotarydrive unit 14 to switch the arrangements of the fluorescence microscopeunit 201 and the weak luminescence microscope unit 202 in switching theobservation of weak luminescence to the observation of fluorescence.

Thus, according to the microscope apparatus 200 in the secondembodiment, the fluorescence microscope unit 201 and the weakluminescence microscope unit 202 are rotated and moved by the rotarydrive unit 14, and the observation of fluorescence is switched to theobservation of weak luminescence. Therefore, the observation offluorescence and the observation of weak luminescence can be switchedimmediately even when the specimen which cannot be moved at high speed,for example, the specimen immersed in a culture solution, is observed.

In this regard, in the microscope apparatus 200, the whole of eachmicroscope unit 201, 202 is rotated and moved by the rotary drive unit14. It may be configured that the imaging devices 3 and 13 are sharedwith one imaging device and the arrangement may be mutually switched byrotating and moving the portion obtained by excluding the imaging device3 from the fluorescence microscope unit 201 and the portion obtained byexcluding the imaging device 13 from the weak luminescence microscopeunit 202.

FIG. 28 is a schematic diagram of the configuration of a microscopeapparatus thus configured. As shown in FIG. 28, a microscope apparatus300 as the modification of the second embodiment removes the imagingdevice 13 from the microscope apparatus 200. The microscope apparatus300 includes a casing 24 that integrally holds a weak luminescenceimaging optical system in place of the casing 22 that integrally holdsthe whole weak luminescence microscope unit 202, and also includes acasing 23 that holds the portion obtained by excluding the imagingdevice 3 in place of the casing 21 that integrally holds the wholefluorescence microscope unit 201. The microscope apparatus 300 includesa control device PC3 in place of the control device PC2. Otherconfigurations are the same as those of the microscope apparatus 200,and the same numeral references are applied to the same structuralparts.

The control device PC3 controls the movement of the imaging device 3,the excitation light source 4, and the stage driving unit 18 as well asthe movement of the rotary drive unit 14 in the same manner as thecontrol device PC2. However, the control device PC2 switches the controlof the imaging devices 3 and 13 depending on the observation offluorescence and the observation of weak luminescence, while the controldevice PC3 controls the imaging device 3 to capture a specimen image inthe case of both the observation of fluorescence and the observation ofweak luminescence. At this time, the control device PC3 recognizesswitching the range of the specimen image to be captured, the imagingmagnification, and the like by the imaging device 3 depending on theobservation of fluorescence and the observation of weak luminescence.

The rotary drive unit 14 holds the casings 23 and 24 by the fixed shafts15 a and 15 b and switches the arrangement of the casings 23 and 24 inaccordance with instructions from the control device PC3 depending onthe observation of weak luminescence and the observation offluorescence.

Thus, according to the microscope apparatus 300 as the modification ofthe second embodiment, the portion in which the imaging devices 3 and 13are removed from the fluorescence microscope unit 201 and the weakluminescence microscope unit 202 is rotated and moved by the rotarydrive unit 14, and the observation of fluorescence is switched to theobservation of weak luminescence. Therefore, the weight of the movingsection is reduced, so that movement and switching can be performed at afaster pace. Further, as for the microscope apparatus 300, the number ofimaging devices is reduced compared with the microscope apparatuses 100a and 200. This allows for simplifying a circuit configuration relatedto the imaging device, reducing the processing load of the controldevice PC3, and speeding up the processing. An apparatus can be producedat low cost.

The microscope apparatuses 200 and 300 are configured such that thefluorescence microscope unit 201 and the weak luminescence microscopeunit 202, or one part of each unit are rotated and moved by the rotarydrive unit 14, while the arrangement of each unit 201 and 202 may beswitched by, not limiting to the rotational movement, for example,moving the fluorescence microscope unit 201 and the weak luminescencemicroscope unit 202 in parallel along the movable stage 17 b.

Third Embodiment

Next, a third embodiment of the present invention will be described. Inthe first and second embodiments described above, the fluorescenceimaging optical system and weak luminescence imaging optical system thatare arranged on the same side with respect to the specimen S and areindependent are included. On the other hand, in the third embodiment,the fluorescence imaging optical system and weak luminescence imagingoptical system that share a portion of optical systems are included.

FIG. 29 is a schematic diagram of the configuration of a microscopeapparatus according to the third embodiment of the invention. As shownin FIG. 29, a microscope apparatus 400 according to the third embodimentshares the objective lenses of the fluorescence imaging optical systemand the weak luminescence imaging optical system in which the microscopeapparatus 100 a separately includes and has an integrated microscopeunit. Specifically, the microscope apparatus 400 includes the samemicroscope unit as the fluorescence microscope unit 101 included in themicroscope apparatus 100 a, and further includes a mirror 34 that isinsertable and detachable between the objective lens 1 included in themicroscope unit and the fluorescence cube 6. The microscope apparatus400 also includes an imaging lens 32 in place of the imaging lens 12,and an imaging device 13 on the optical axis that is bent about 90degrees leftwards in the drawing by the mirror 34.

Thus, the microscope apparatus 400 shares the objective lens 1 and has afluorescence imaging optical system with the objective lens 1 and theimaging lens 2, and a weak luminescence imaging optical system with theobjective lens 1 and the imaging lens 32. Further, the microscopeapparatus 400 has the holding unit 17 and the stage driving unit 18included in the microscope apparatus 200. The microscope apparatus 400also has a shutter 33 as non-irradiating means between the excitationlight source 4 and the lens 5, an optical path switch driving unit 35that operates the shutter 33 and the mirror 34, and a control devicePC4. Other configurations are the same as those of the first and secondembodiments, and the same numeral references are applied to the samestructural parts.

The control device PC4 controls the movement of the imaging devices 3and 13 and the stage driving unit 18 in the same manner as the controldevice PC2, and controls the movement of the shutter 33 and the mirror34 through the optical path switch driving unit 35. The control devicePC4 removes the mirror 34 from between the objective lens 1 and thefluorescence cube 6, opens the shutter 33 and irradiates the specimen Swith excitation light from the excitation light source 4 when switchingfrom the observation of weak luminescence to the observation offluorescence. On the other hand, the control device PC4 closes theshutter 33 so as to shield the excitation light from the excitationlight source 4, does not irradiate the specimen S with the excitationlight, inserts and arranges the mirror 34 on the optical path betweenthe objective lens 1 and the fluorescence cube 6, and reflects the weakluminescence from the specimen S to the imaging lens 32 when switchingfrom the observation of weak luminescence to the observation offluorescence.

The imaging lens 32 has a focal length shorter than the imaging lens 2.The weak luminescence imaging optical system with the imaging lens 32forms a weak luminescent specimen image at an imaging magnificationlower than that of the fluorescence imaging optical system with theimaging lens 2. Further, it is desirable that the weak luminescenceimaging optical system with the imaging lens 32 satisfies(NAo′/β′)²≧0.01 when NA on the side of the specimen is defined as NAo′and an imaging magnification is defined as β′.

Thus, according to the microscope apparatus 400 in the third embodiment,it is configured to include a microscope unit that is integrated by thefluorescence imaging optical system and weak luminescence imagingoptical system that share the objective lens. Therefore, miniaturizationand simplification of the whole microscope apparatus can be achieved.Further, the moving section due to the switching of the observation offluorescence and the observation of weak luminescence becomes a singleoptical element and the weight is reduced, so that movement andswitching can be performed at a faster pace.

When the range of wavelengths of excitation light from the excitationlight source 4 and fluorescence from the specimen S is different fromthe range of wavelengths of weak luminescence from the specimen S, adichroic mirror that transmits excitation light and fluorescence andreflects weak luminescence may used in place of the mirror 34. In thiscase, the control device PC4 does not need to insert and detach adichroic mirror in switching the fluorescent observation and the weakluminescent observation. When a dichroic mirror is used, the controldevice PC4 may control to perform the fluorescent observation and theweak luminescent observation at the same time.

Fourth Embodiment

Next, a fourth embodiment of the present invention will be described. Inthe first embodiment mentioned above, the fluorescence microscope unit101 and the weak luminescence microscope unit 102 a are arranged on thesame side to the specimen S. On the other hand, in the fourthembodiment, the fluorescence microscope unit and the weak luminescencemicroscope unit are arranged on the opposite sides across the specimenS.

FIG. 30 is a schematic diagram of the configuration of a microscopeapparatus according to the fourth embodiment of the invention. As shownin FIG. 30, a microscope apparatus 500 according to the fourthembodiment includes the fluorescence microscope unit 101 and weakluminescence microscope unit 102 a included in the microscope apparatus100 a and also includes the holding unit 1 and the stage driving unit 18included in the microscope apparatus 200, and further includes a controldevice PC5 and a monitor 9. The same numeral references are applied tothe same structural parts as that of the first and second embodiments.

In the microscope apparatus 500 shown in FIG. 30, the fluorescencemicroscope unit 101 is arranged on the downside of the specimen S (inthe drawing) and the weak luminescence microscope unit 102 a is arrangedon the upside of the specimen S. Here, the up-and-down arrangementbetween respective units 101 and 102 a may be reversed.

The control device PC5 controls the movement of the imaging devices 3and 13, the excitation light source 4, and the stage driving unit 18 inthe same manner as the control device PC2. When switching from theobservation of weak luminescence to the observation of fluorescence, thecontrol device PC5 turns on the excitation light source 4 to irradiatethe specimen S with excitation light. When switching from theobservation of fluorescence to the observation of weak luminescence, thecontrol device PC 5 turns off the excitation light source 4 so as not toirradiate the specimen S with excitation light.

In this regard, a shading device such as a shutter 33 is provided on theoptical path from the excitation light source 4 to the specimen Sthrough the dichroic mirror 6 c, and the control device PC5 may beconfigured to control irradiation and nonirradiation of excitation lightby opening and closing the shading device instead of switching to turnon/off the excitation light source 4 as non-irradiating means.

Alternatively, when the range of wavelengths of excitation light fromthe excitation light source 4 and fluorescence from the specimen S isdifferent from the range of wavelengths of weak luminescence from thespecimen S, for example, a wavelength extracting filter that transmitsweak luminescence and shields excitation light and fluorescence isprovided between the imaging lens 12 and the imaging device 13. Thecontrol device PC5 may switch the observation of fluorescence and theobservation of weak luminescence without turning off the excitationlight source 4. Alternatively, in this case, the control device PC5 maycontrol so that the observation of fluorescence and the observation ofweak luminescence are performed at the same time.

Thus, according to the microscope apparatus 500 according to the fourthembodiment, the fluorescence microscope unit 101 and the weakluminescence microscope unit 102 a are mutually arranged on the oppositesides across the specimen S. Consequently, the observation offluorescence and the observation of weak luminescence can be switchedimmediately without mechanical driving.

The control device PC5 relatively may move the fluorescence microscopeunit 101 to the weak luminescence microscope unit 102 a along themovable stage 17 b by a driving mechanism (not illustrated). In thiscase, while the wide range region of the specimen S is continued to beobserved by the weak luminescence microscope unit 102 a, an enlargedimage of an arbitrary micro region in this wide range region can beobserved by fluorescence microscope unit 101, and the observation offluorescence and observation of weak luminescence can be performedwithout completely moving the specimen S.

Fifth Embodiment

Next, a fifth embodiment of the present invention will be described. Inthe first to fourth embodiments mentioned above, the specimen S isobserved by weak luminescence and fluorescence from a luminescent labeland a fluorescent label. On the other hand, in the fifth embodiment, thespecimen S is observed by transmitted illumination.

FIG. 31 is a schematic diagram of the configuration of a microscopeapparatus according to the fifth embodiment of the invention. As shownin FIG. 31, a microscope apparatus 600 according to the fifth embodimentincludes a transmitted illumination unit 103 a as illuminating means toperform transmitted illumination, an illumination driving unit 46 thatdrives a shutter 43 included in the transmitted illumination unit 103 a,and a control device PC6 in place of the control device PC1 in additionto the microscope apparatus 100 a in the first embodiment. Otherconfigurations are the same as those of the first embodiment, and thesame numeral references are applied to the same structural parts.

The transmitted illumination unit 103 a includes a white light source 44such as a halogen lamp that emits white light for transmittedillumination, a shutter 43 that switches irradiation and nonirradiationof white light, and an illuminating lens system 45 that concentrateswhite light from the white light source 44 on the specimen S and it isarranged on the opposite side to the fluorescence microscope unit 101 tothe specimen S. The illuminating lens system 45 has a collector lens 45a and a condenser lens 45 b and performs critical illumination to thespecimen S. In this regard, the illuminating lens system 45 may performKoehler illumination to the specimen S.

The illumination driving unit 46 drives the shutter 43 and a fluorescentlighting unit 104 a in accordance with instructions of the controldevice PC6. Here, the fluorescent lighting unit 104 a has the excitationlight source 4, a lens 5, and a fluorescence cube 6 that are integrallyheld by a casing 26. The illumination driving unit 46 switchesirradiation and nonirradiation of white light to the specimen S byopening and closing the shutter 43, and moves the fluorescent lightingunit 104 a so that the fluorescence cube 6 is inserted and detached onthe optical path between the objective lens 1 and the imaging lenses 2.

The control device PC6 controls the movement of the imaging devices 3and 13, the excitation light source 4, and the stage driving unit 8 inthe same manner as the control device PC1, and controls the movement ofthe illumination driving unit 46. When switching from the observation offluorescence to the observation of transmitted illumination, the controldevice PC6 moves the fluorescent lighting unit 104 a so as to remove thefluorescence cube 6 from between the objective lens 1 and the imaginglens 2, turns off the excitation light source 4, and opens the shutter43, thereby performing transmitted illumination. When switching from theobservation of transmitted illumination to the observation offluorescence, the control device PC6 closes the shutter 43 and moves thefluorescent lighting unit 104 a so that the fluorescence cube 6 isarranged between the objective lens 1 and the imaging lenses 2, therebyturning on the excitation light source 4.

When switching from the observation of weak luminescence to theobservation of transmitted illumination, the control device PC6 drivesthe movable stage 7 b by the stage driving unit 8 in addition to thecontrol when switching from the observation of fluorescence to theobservation of transmitted illumination, and controls to move thespecimen S to the visual field of the fluorescence imaging opticalsystem. The control device PC6 may turn on and off the white lightsource 44 instead of opening and closing the shutter 43.

It is described that the transmitted illumination unit 103 a performsillumination for bright field observation, but it is not limited to thebright field observation. The transmitted illumination unit 103 a mayperform illumination for dark field observation, differentialinterference observation, or phase difference observation.Alternatively, the illumination for these various observations may beswitchably included in the unit. When illumination for differentialinterference observation is performed, the transmitted illumination unit103 a may include a polarizer and a polarized light separating prism onthe light source side of the condenser lens 45 b, and a fluorescenceimaging optical system may be configured so that a polarizationsynthetic prism and an analyzer are arranged in the pupil side of theobjective lens 1. It is preferable that when performing illumination forphase difference observation, the transmitted illumination unit 103 a isconfigured to have a ring slit on the light source side of the condenserlens 45 b, and the fluorescence imaging optical system is configured sothat a phase plate is arranged at an almost pupil position of theobjective lens 1 or the objective lens 1 is switched to the objectivelens having a phase plate. Further, it is preferable that whenperforming illumination for dark field observation, the transmittedillumination unit 103 a may be configured to have a ring slit, or thelike on the light source side of the condenser lens 45 b.

The transmitted illumination unit 103 a is arranged responsive to thefluorescence imaging optical system in order to perform the observationby transmitted illumination at high magnification, while it may bearranged responsive to the weak luminescence imaging optical system inorder to observe at low magnification. Alternatively, it may be arrangedresponsive to both these imaging optical systems, or the arrangement maybe properly switched for each imaging optical system.

Meanwhile, the microscope apparatus 600 is configured such that thetransmitted illumination unit 103 a and the illumination driving unit 46are further included in the configuration of the microscope apparatus100 a, but it is not limited thereto. For example, as shown in FIGS. 32to 34, the transmitted illumination unit 103 a and the illuminationdriving unit 46 or the illumination driving unit 47 may be furtherincluded in each configuration of the microscope apparatuses 200, 300,and 400.

A microscope apparatus 700 shown in FIG. 32 is a case where thetransmitted illumination unit 103 a and the illumination driving unit 46are further included in the configuration of the microscope apparatus200. A control device PC7 controls the imaging devices 3 and 13, theexcitation light source 4, the rotary drive unit 14, and the stagedriving unit 18 in the same manner as the control device PC2, andcontrols the transmitted illumination unit 103 a and the fluorescentlighting unit 104 a by the illumination driving unit 46 in the samemanner as the control device PC6.

A microscope apparatus 800 shown in FIG. 33 is a case where thetransmitted illumination unit 103 a and the illumination driving unit 46are further included in the configuration of the microscope apparatus300. A control device PC8 controls the imaging devices 3, the excitationlight source 4, the rotary drive unit 14, and the stage driving unit 18in the same manner as the control device PC3, and controls thetransmitted illumination unit 103 a and the fluorescent lighting unit104 a by the illumination driving unit 46 in the same manner as thecontrol device PC6.

A microscope apparatus 900 shown in FIG. 34 is a case where thetransmitted illumination unit 103 a and the illumination driving unit 47are further included in the configuration of the microscope apparatus300. A control device PC9 controls the imaging devices 3 and 13, and thestage driving unit 18 in the same manner as the control device PC4, andcontrols the transmitted illumination unit 103 a, the mirror 34, and thefluorescent lighting unit 105 by the illumination driving unit 47.

That is, when switching from the observation of fluorescence or theobservation of weak luminescence to the observation of transmittedillumination, the control device PC9 moves the fluorescent lighting unit105 so as to remove the fluorescence cube 6 from between the objectivelens 1 and the imaging lens 2, and closes the shutter 33 not toirradiate with excitation light and opens the shutter 43 to performtransmitted illumination. When switching from the observation oftransmitted illumination to the observation of fluorescence or weakluminescence, the control device PC9 closes the shutter 43 and moves thefluorescent lighting unit 105 or mirror 34 so that the fluorescence cube6 or the mirror 34 is arranged between the objective lens 1 and theimaging lenses 2, thereby turning on the excitation light source 4. Whenthe fluorescent observation is performed, the shutter 33 is opened toirradiate the specimen S with fluorescent light.

Thus, according to microscope apparatuses 600, 700, 800, and 900 in thefifth embodiment, the apparatuses are configured to correspond to atleast one of a fluorescence imaging optical system and a weakluminescence imaging optical system, and include a transmittedillumination unit that performs transmitted illumination to the specimenS. Therefore, not only fluorescent and weak luminescent observations butalso observations by various kinds of transmission illumination can beperformed, and the specimen S can be observed from various angles.

The microscope apparatuses 100 a, 200, 300, 400, 600, 700, 800, and 900mentioned above are shown as upright microscope apparatuses, where theymay be inverted microscope apparatuses. Further, the above-mentionedmicroscope apparatus can be preferably used in, for example,examinations of various types of reactions (for example, drugstimulation, or light exposure) or treatments.

As mentioned above, the embodiments have been described in detail. Inthe present invention, the term “luminescence” means that light may begenerated by chemical reactions and the term includes particularly,bioluminescence and chemiluminescence as preferable examples. On theother hand, the term “fluorescence” means that light may be generated byexcitation light. Here, BRET (bioluminescence resonance energy transfer)that is excited by the light energy due to bioluminescence is includedin the term “luminescence” in the present invention since the dominantfactor is the chemical reaction with a substrate solution. Theluminescence generated from samples is an electromagnetic radiation withwavelengths between about 400 nm to about 900 nm that is less harmful toparticularly living cells. In the image capture of the sample, it isnecessary to use an optical power detector which detects a very lowlevel light (usually, a single photon phenomenon) and can integrate withphoton radiation until the construction of an image is attained.Examples of such a high sensitive photodetector include a camera or acamera group in which a single photon can be detected in uniquebackground noise to the detection system after amplifying single photonphenomenon. For example, the CCD camera having an image sensor grouplike CCD can be illustrated. Generally, in some cases, a CCD camera iscooled with liquid nitrogen, and the like in order to obtain highsensitivity. It was confirmed by the present inventors that an imagecould be formed even when the cooling temperature is −5° C. to −20° C.,preferably −5° C. to normal temperature in the case where an objectivelens with a high numerical aperture (NA), especially, the opticalcondition represented by the square of numerical aperture(NA)/projecting magnification (β) is 0.01 or more is used. As a resultof further examination, it is found out that when the square of theabove-mentioned optical condition (NA/β) is 0.071 or more, a cell imagethat can be visually recognized 5 minutes or less or in some cases about1 minute and can be analyzed can be provided. Generally, when the imagecapture time exceeds 30 minutes, it is difficult to obtain a clearluminescent image of live samples in many cases due to changes of theshape or the luminescence site. Therefore, the present inventionprovides the method and apparatus which obtain one luminescent image ina short time, particularly, 30 minutes or less, preferably, for 1 minuteto 10 minutes and are advantageous to cooperate with fluorescencemeasurement that takes a short time to capture an image.

For example, as a related aspect, a series of images can be constructedby repeating the measurement of photon radiation or the image capture atthe selected time interval when the localization of a fluorescent signaland/or the intensity of a luminescence signal serial is tracedsequentially in order to record the distribution of the componentcompatible with the selected organism and/or the effect of a certaintreatment to localization. The interval may be a short interval such asabout several minutes, or a long interval such as about several days orseveral weeks. A luminescent image or a superposed image of fluorescence(or transmitted light) and luminescence can be expressed in variousforms, such as a printed paper and an image in which graphics isprocessed.

As another related aspect, the present invention includes a method ofmonitoring the activity of a promoter induction event after detectingthe presence of the promoter induction event in a transgenic animal or achimera animal which are transformed with a construction containing thegene coding for a luminescent protein under the control of an induciblepromoter. Examples of a promoter induction event include administrationof the substance which directly activates the promoter, administrationof the substance which stimulates the production of an endogenouspromoter activator (for example, stimulation of the interferon producedby RNA virus infection), leaving in the state inducing the production ofan endogenous promoter activator (for example, heat shock or stress),and the like.

As another aspect, the present invention also includes a method ofidentifying a compound for treatment which is effective in inhibitingthat pathogenic infection becomes severe. In this method, a complex of apathogen, a fluorescent component, and a luminescent component isadministered to control animals and laboratory animals, or theircultured tissues (or cells) and the laboratory animals are treated witha candidate compound for treatment. After confirming the localization ofa fluorescent signal in the samples to be measured by theabove-mentioned method, a luminescent signal (bioluminescence orchemiluminescence) is continuously measured in the sample in which thelocalization is found. In this way, the therapeutic efficiency of thecompound can be monitored.

Further, as another aspect, the present invention includes a method ofpassing a sample through media of various opacities, selecting thelocalized sample by a fluorescent signal, and then successivelymeasuring the luminescence from the sample in which localization isconfirmed. In this method, while an image can also be created byintegrating a luminescent signal with photon which transmitted themedium, the method can be modified so that only the sample in whichlocalization is confirmed is surgically removed from media (for example,organ tissue) and the luminescence of the removed sample is measured insuitable incubation atmosphere. The limited surgical operation (forexample, biopsy) has the advantage that physical burden to originalorganisms (for example, mammals, especially humans) is reduced, and onlyrequired sample is placed in the stable environment for examination, sothat the response to a variety of prospective medicines, the monitoringafter the treatment, and preventive medicine test can be carried out fora long period of time.

As a further aspect, the present invention may include a method formeasuring the concentration of the selected substance (for example,dissolved oxygen or calcium) at the predetermined site in a certainorganism.

In the above description, according to the present invention, it is alsopossible to provide an analytical reagent for bioluminescence imageanalysis (or imaging analysis) as shown below. Especially, in theexemplary embodiments of the invention, a method, a reagent, and anapparatus for analyzing any biological activities (enzyme activity,immunological activity, molecular biological activity, genetic activity,and internal medicine activity etc.) of biological samples which mainlycontain isolated cells or cell populations which do not contain opaquetissue, are provided. Here, the cells or cell populations which areisolated are stored in a storing container (for example, a well a petridish, a microslide, a chip for microfluidics) that mainly consists ofmaterials with high optical transparency for a long period of time.Therefore, unique reagents or reagent environments for minimizing theloss of intracellular activity or capturing without substantialinactivation are provided.

1. Reagents Regarding the Long-Term Use of Substrate and HandlingThereof.

When intracellular activity of the sample is maintained, for example,from several hours to 24 hours, from 2 to 6 days, 1 week to severalweeks, or several weeks or more by a technique such as prolongedculture, handling with the following characteristics is important inorder to produce luminescence. Some methods and/or reagents which willbe described hereinbelow may be used alone. However, the invention isnot limited thereto since in some cases, it is preferable to use severalmethods in combination.

(A First Handling Method)

Current reagents for bioluminescence, commercially available orreported, are substrates which can be used for observation up to 24hours. However, when used for 24 hours or more, for example, severalweeks, replenishment of a substrate is needed. A method of addingsubstrates to the culture medium in which cells or cell populations areplaced at regular time intervals or in coincidence with the start ofmeasurement is preferable. As a reagent kit suitable for adding severaltimes, it is preferable to have holding means (container or bag) thatincludes a luminescent reagent containing a photoprotein that isenclosed in the same package and holding means (container or bag) thatseparately contains a substrate solution (or substrate-containingculture solution) with the amount corresponding to a luminescent reagentso as to be sufficient for using several times.

(A Second Handling Method)

In another aspect, PH adjustment is carried out over a long period oftime. Thus, this method is a method of keeping concentration of CO₂ gasas gaseous environment at a constant concentration or more. Moreparticularly, it is a method of maintaining a high concentration of gaswhich is higher level than the minimum level required for cells tosurvive. On the other hand, an apparatus is designed so that asufficiently large volume of gaseous environment is stored in a storagecontainer (for example, a gas tank) that stores a pressure more thanatmospheric pressure and the gases travel from the container to cells(or cell populations) periodically or gradually. Preferably, the localmovement of gaseous environment is set to the rate equivalent to themetabolic rate of cells (or cell populations) to gases.

(A Third Handling Method and Reagent)

HEPES, which is known to ensure a constant PH for a long time, is added.In the same manner as the case of the above-mentioned gaseousenvironment, HEPES can be supplied depending on the concentration ofHEPES associated with the consumption rate of the solid, liquid, and gaswhich are consumed by cells (or cell populations). It is more preferablethat HEPES is enclosed in a sustained-release capsule, publicly known,and an effective number of capsules is contained in a solution or aculture medium together with cells (or cell populations). The solutionand culture medium which mainly contain a sustained-release capsule inwhich an effective amount of HEPES (or a compound for maintaining a PHequivalent to HEPES) is enclosed can become an effective reagent forachieving the objective of the present invention.

(A Fourth Handling Method, Apparatus or Reagent)

According to the spirit of the present invention, there is provided anapparatus for keeping warm and/or a medicament for adjusting internaltemperature of cells or cell populations to the level that does notcause a fatal change.

(A Fifth Handling Method or Reagent)

This description relates to a method and/or a reagent for keeping thebackground of luminescence detections low over a long period of time.Namely, a method of removing a tissue fragment, a coloring matter (forexample, a chromogenic dye substance, especially phenol red dye) as anelement related to the increase in the background by bioluminescence (orchemiluminescence) can be provided, or a culture medium or solution inwhich such elements are sufficiently removed in advance can be providedas a reagent.

(A Sixth Handling Method or Reagent)

Passing a substrate through cells, particularly cell populations, isimportant in the stability of luminescence or measurement accuracy. Asthis method, a treatment that helps the substrate penetrate cellmembrane (for example, a pressure shock or an electric shock) can becarried out continuously and intermittently or depending on the aging ofcells. The substrate or special buffer solution which contains anadditive which supports or facilitates the cell membrane permeability(for example, a surfactant as a membrane lytic substance, salts asmembrane osmotic pressure modified substances) can be provided as areagent. Preferably, these methods and/or reagents are set so that thepermeability to a fresh extracellular substrate can be maintainedwithout shortage of active substrates in cells during long-termmeasurements or the permeability is temporarily increased.

(A Seventh Handling Method)

This description relates to a method for achieving uniform staining.Magnetic beads are added in advance and then stirring is carried out forseveral hours or once a day. Usually, cells are stuck on the bottom of acontainer to be charged, and therefore it is preferable to first stirthe upper layer of the container.

(An Eighth Handling Method or Reagent)

When long-term observations are carried out, byproducts are generated byrepeatedly performing many luminescent reactions in the same cell (orcell population), which cause optical inhibition or chemical inhibition.This description relates to a method or reagent for eliminatinginfluence of such inhibition. That is, the reaction byproducts generatedby luminescent reaction are accumulated depending on the handling suchas replenishment of a substrate. In order to remove the byproducts(pyrophoric acid) caused by this luminescent reaction, substances toeliminate byproducts (for example, metal ions which produceprecipitation) are added.

(A Ninth Handling Method or Reagent)

This description relates to a method or reagent for regeneratingluciferin as a luminescent component. After emitting light as a resultof luciferase reaction, luciferin is converted to oxyluciferin. A methodof supplying a reagent to convert oxyluciferin to luciferin to cells (orcell populations) in accordance with aging or loss of luciferin isprovided. In the case of a firefly, it is known that the detectedoxyluciferin is converted into nitrile 2 and then it reacts withcysteine in the body as used in the synthesis, thereby regeneratingluciferin. It is also possible to provide a substrate containing aregenerative material to regenerate the decreased activity of such aluminescent component or a special buffer solution. Other examples ofthe substrate include coelenterazine.

(A Tenth Handling Method or Reagent)

This description relates to an encapsulation substrate as a novelreagent. A suitable substrate (for example, luciferin) is enclosed in acapsule that is eluted or released after a predetermined time or atregular time intervals in order to maintain a given concentration of thesubstrate. Further, a method for providing a substrate (for example,luciferin) which is not enclosed in a capsule and the same kind ofsubstrate which is enclosed in a capsule at the same time, or a reagentwhich is a solution contained in the capsule in a mixed state can beprovided. Furthermore, there is an advantage that a fresh substrate canbe automatically provided at different release times by adding a reagentin which the same kind of substrate (for example, luciferin) iscontained in two or more capsules with a different rate of gradualrelease (or contacting with a culture medium) together with cells (orcell populations) at the same time. In this way, the timing whenexcitation light is irradiated can be coordinated with the timing whensubstrate is released.

Example 1

Here, the amounts of luminescence and ATP from mitochondria in specificHeLa cells are measured sequentially in multiple HeLa cells into whichthe plasmid vector shown in FIG. 10 is introduced using thepredetermined site luminescence measuring apparatus 100 in theembodiment described above.

First, an experimental protocol in Example 1 will be described.

(1) A fusion gene in which a fluorescence protein (GFP), a mitochondrialtargeting signal, and luciferase are linked is prepared.

(2) A plasmid vector containing a fusion gene (refer to FIG. 10) isintroduced into a HeLa cell.

(3) Localization of luciferase in mitochondria is confirmed bydetermining whether GFP is localized in the mitochondria using thepredetermined site luminescence measuring apparatus 100 (specifically,an inverted fluorescence microscope forming the apparatus) in theembodiment described above (refer to FIG. 11). FIG. 11 is a view of thebright-field image and fluorescent image of a HeLa cell into which theplasmid vector is introduced, which are captured by the fluorescentimage capturing unit 108 forming the predetermined site luminescencemeasuring apparatus 100.

(4) Histamine is administered to HeLa cells to induce changes in theamount of ATP in mitochondria through Ca²⁺.

(5) The luminescence emitted from mitochondria is sequentially obtainedas an image using the predetermined site luminescence measuringapparatus 100 in the embodiment described above (refer to FIG. 12). FIG.12 is a view of the bright-field image and luminescent image of a HeLacell into which the plasmid vector is introduced, which are captured bythe luminescent image capturing unit 106 forming the predetermined siteluminescence measuring apparatus 100.

(6) The cells to be measured are selected by superimposing abright-field image on a fluorescence image or a luminescence image usingthe predetermined site luminescence measuring apparatus 100 in theembodiment described above.

(7) The luminescence intensity of the selected cells or regions issequentially measured (refer to FIG. 13) and changes in the amount ofATP are monitored using the predetermined site luminescence measuringapparatus 100 in the embodiment described above. FIG. 13 is a view ofchanges over time in the luminescence intensity of the specified HeLacell No. 1 which is measured with the predetermined site luminescencemeasuring apparatus 100.

Next, experimental results will be described. As shown in FIG. 11, asfor the HeLa cell No. 1, it was found that the fusion gene wasintroduced by the plasmid vector and luciferase was localized inmitochondria. Further, as for in HeLa cells No. 2 and 4, it was foundthat a fusion gene was not introduced by the plasmid vector.

Furthermore, as for a HeLa cell No. 3, it was found that a fusion genewas introduced by the plasmid vector, but luciferase was not localizedin mitochondria. In this regard, a HeLa cell in which the introductionof a fusion gene by the plasmid vector and the localization ofluciferase in mitochondria were both found was the HeLa cell No. 1 only,and therefore the HeLa cell for measurement was identified as the HeLacell No. 1. As shown in FIG. 12, it was confirmed that luminescence fromthe HeLa cell No. 3 was the strongest, luminescence from the HeLa cellNo. 1 was the second strongest, and the strength of luminescence fromthe HeLa cell No. 2 is equal to that from the HeLa cell No. 4. As shownin FIG. 13, the time course of the luminescence intensity frommitochondria of the HeLa cell No. 1 could be monitored by using thepredetermined site luminescence measuring apparatus 100.

Example 2

In this Example, luminescence and fluorescence of the HeLa cells areobserved in the HeLa cells into which luciferase genes and greenfluorescence protein (GFP) genes were introduced using the predeterminedsite luminescence measuring apparatus 100 of the embodiment describedabove, as shown in FIG. 16.

First, an experimental protocol in Example 2 will be described.

(1) The luciferase gene and the green fluorescence protein (GFP) genesare tandemly arrayed and then a vector (EGFP-Luc: manufactured byClonetech) is located, which is introduced into HeLa cells by theLipofectin method.

(2) About 24 hours after the introduction of the vectors, 500 μM ofluciferin is added to a culture solution (D-MEM, GIBCO: manufactured byInvitrogen) containing the HeLa cells into which the vectors areintroduced.

(3) A container to which the culture solution is added is placed on thestage 104 of the predetermined site luminescence measuring apparatus 100as shown in FIG. 16 and then the bright-field image, fluorescent image,and luminescent image of the HeLa cells are captured using thepredetermined site luminescence measuring apparatus 100. When afluorescent image was captured, a spectral filter for excitation 108 gand a filter for luminescence and fluorescence spectra 108 j were placedand exposure time in the image capturing was 0.7 seconds. When capturinga luminescent image, the filter for luminescence and fluorescencespectra 108 j was removed and the exposure time in the image capturingwas 5 minutes. Here, in Example 2, “Uapo 20×: manufactured by OlympusCorporation” that has a focal length (f) of 9 mm and a NumericalAperture (NA) of 0.75 was used as an objective lens 108 a. Further,“LMPlanFL 10×: manufactured by Olympus Corporation” having a focallength (f) of 18 mm, a Numerical Aperture (NA) of 0.25, and the value of0.035 found by “(NA/β)²” was used as an imaging lens 108 e. A halogenlight source “LG-PSs: manufactured by Olympus Corporation” was used as alight source 108 c. “DP-30BW: manufactured by Olympus Corporation” wasused as a CCD camera 108 d. “BP470-490: manufactured by OlympusCorporation” was used as the spectral filter for excitation 108 g.Furthermore, “510AF23: manufactured by Omega” was used as the filter forluminescence and fluorescence spectra 108 j.

Next, the results of observation will be described. FIG. 17 is a view ofthe fluorescent image of a HeLa cell into which a vector (EGFP-Luc gene)is introduced. FIG. 18 is a view of superimposed images of thefluorescent image and bright-field image of the HeLa cell into which thevector (EGFP-Luc gene) is introduced. FIG. 19 is a view of theluminescent image of the HeLa cell into which the vector (EGFP-Luc gene)is introduced. As shown in FIGS. 17, 18, and 19, the transfected HeLacells could be specified by fluorescent observation using thepredetermined site luminescence measuring apparatus 100, and further thespecified HeLa cells were focused and then the luminescent image couldbe captured.

Example 3

In this example, the amount of expression of the gene to be analyzed ismeasured by luminescence (promoter assay for the gene to be analyzed),while the stage of the cell cycle is identified by fluorescence usingthe expression amount measuring apparatus 1000 as described in theembodiments.

First, vectors to be introduced into cells are produced. Specifically,the cell cycle-related gene promoter containing luciferase (green)expression vector is produced. The type of cells to be used is PC12.Next, the produced vectors are transfected into cells (transfection).Then, the cell membrane of the cell is stained with “PKH LinkerKits(red): manufactured by SIGMA”. Thereafter, promoter assay of the cellcycle-related gene, the gene to be analyzed, is performed while thestage of the cell cycle is identified using the expression amountmeasuring apparatus 1000. Thus, the relationship between the cell cycleand morphology of cells could be examined.

Example 4

In this example, the amount of expression of the gene to be analyzed ismeasured by fluorescence and the expression period of the genes and thelocalization of the genes are identified, while the stage of the cellcycle is identified by luminescence using the expression amountmeasuring apparatus 1000 as described in the embodiments.

First, vectors to be introduced into cells are produced. Specifically,the fluorescent protein vector into which the gene promoter for analysisis introduced is produced. Then, HaloTag (registered trademark) vector(manufactured by Promega KK) is introduced into cells. The type of cellsto be used is PC12. Cells are labeled with luciferase by adding HaloTag(registered trademark) ligand (manufactured by Promega KK) thereto. Thatis, cells are luciferase-labeled by the ligand binding to HaloTag(registered trademark) (manufactured by Promega KK). Then, theexpression period of the gene to be analyzed which can be involved inthe cell cycle and their localization are identified while the stage ofthe cell cycle is monitored using the expression amount measuringapparatus 1000. This allowed for evaluating whether there is arelationship between the gene to be analyzed and the cell cycle, and theusefulness of the gene to be analyzed as a cell-cycle marker.

INDUSTRIAL APPLICABILITY

As described above, the predetermined site luminescence measuringmethod, and the predetermined site luminescence measuring apparatus inthe present invention are useful when measuring the luminescence fromthe predetermined site in living samples. In addition, the expressionamount measuring method in the present invention is useful whenmeasuring the amount of expression in the gene to be analyzed which areintroduced into living cells as well as identifying the stage of thecell cycle, and can be advantageously used in various fields such asbiotechnology, medicine manufacture, and medical care.

1. A measuring apparatus comprising: an imaging optical system whichforms a specimen which is labeled with a luminescent label emitting weakluminescence and a fluorescent label emitting fluorescence by excitationand held by a holding unit; and a capturing unit that captures thespecimen image, wherein the measuring apparatus share a common unitincluding the imaging optical system and the capturing unit forperforming both fluorescent observation and luminescent observation, andthe common unit uses a common objective lens.
 2. The measuring apparatusaccording to claim 1, further comprising an illuminating unit thatcorresponds to the imaging optical system, to transmit illumination tothat specimen.
 3. The measuring apparatus according to claim 2, whereinthe transmitted illumination is at least one of illumination for brightfield observation, illumination for dark field observation, illuminationfor differential interference observation, and illumination for phasecontrast observation.
 4. The measuring apparatus according to claim 1,wherein the imaging optical system has a value calculated by (NAo/β)² of0.01 or more, where NAo is a numerical aperture on the side of thespecimen of the imaging optical system, and β is a magnification forforming the specimen image.
 5. The measuring apparatus according toclaim 2, wherein the illuminating unit includes a shutter, a dichroicmirror, and a light source set in an optical path for the imagingoptical system.
 6. The measuring apparatus according to claim 1, furthercomprising a light source, and a filter for luminescence andfluorescence spectra.
 7. The measuring apparatus according to claim 2,wherein an optical fiber conducts light from the light source.
 8. Themeasuring apparatus according to claim 6, wherein an optical fiberconducts light from the light source.